Mutation analysis and clinical characterization of Iranian patients with mucopolysaccharidosis type I
PMID: 31386236
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
Mutation analysis and clinical characterization of Iranian patients with mucopolysaccharidosis type I
PMID: 31386236
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
14
Case#: 14, Male, 0.7 years (diagnosed), 8.5 years (report), 9.5 kg (weight), 73 cm (height), Iranian
DiseaseAssertion: Hurler-Scheie Syndrome
FamilyInfo: Parents are consanguineous
CasePresentingHPOs: HP:0001999, HP:0100790 (Facial Dysmorphic Features, Hernia)
CaseHPOFreeText: HM/HSM
CaseNotHPOs: HP:0001249, HP:0000943, HP:0001387, HP:0000365, HP:0007957, HP:0000238 (Mental Retardation, Multiple Dysostosis, Joint Stiffness, Deafness, Corneal Opacity, Hydrocephalus)
CaseNotHPOFreeText: Chronic Rhinorrhea, Cardiac Manifestations
CaseEnzymeAssay: IDUA activity 0.6 (μmol/spot.20h)
CaseUrineGAGs: Quantitative urinary GAG 6.4 (mg/gCr)
CaseERT: N/A
CaseBMT: N/A
GenotypingMethod: Sanger Sequencing
Variant1: p.Y109H
Variant2: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished: N/A
9
Case#: 9, Female, 0.7 years (diagnosed), 1.2 years (report), 6.8 kg (weight), 69 cm (height), Iranian
DiseaseAssertion: Hurler-Scheie Syndrome
FamilyInfo: Parents are consanguineous
CasePresentingHPOs: HP:0100790 (Hernia)
CaseHPOFreeText: HM/HSM, Chronic Rhinorrhea
CaseNotHPOs: HP:0001249, HP:0001999, HP:0000943, HP:0001387, HP:0000365, HP:0007957, HP:0000238 (Mental Retardation, Facial Dysmorphic Features, Multiple Dysostosis, Joint Stiffness, Deafness, Corneal Opacity, Hydrocephalus)
CaseNotHPOFreeText: Cardiac Manifestations
CaseEnzymeAssay: IDUA activity 0.97 (μmol/spot.20h)
CaseUrineGAGs: Quantitative urinary GAG 7.21 (mg/gCr)
CaseERT: N/A
CaseBMT: N/A
GenotypingMethod: Sanger Sequencing
Variant1: p.Y109H
Variant2: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished: N/A
Case#: Patient 2662, northern European origin, 11 years old (age of diagnosis), 22 years old (age at report), male, attended special schools until 15 years old, has not attained the ability to read and write, and has an increasingly poor memory.
DiseaseAssertion: MPS-1H/S, intermediate
FamilyInfo: Two affected younger sisters with MPS1 who presumably have the same R89Q/1060+2t-*-c genotype. he youngest sister died of bronchopneumonia at 22 mo of age. His second sister presented at 2 years and 6 mo of age with good general health, apart from upper respiratory tract infection, coarse facial features, enlarged liver and spleen, and limitation of elbow extension. This sister is now 20 years of age, has coarse facial features and joint limitations, is obese, and has a short stature. She is "bright" and able to live in her own flat with visiting help.
CasePresentingHPOs: Intellectual disability, memory impairment, limited motor development, severe joint contractures, short stature, obesity, macrocephaly, coarse facial features, hearing impairment, visual impairment (HP:0001249, HP:0002354, HP:0002194, HP:0002828, HP:0004322, HP:0001513, HP:0000256, HP:0000280, HP:0000365, HP:0000505)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: Fibroblasts with two monoclonal antibodies detected 7%-10% of the normal levels of IDUA protein compared with only 1.5% of IDUA protein in a R89Q/W402X compound heterozygote
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.266G>A (p.R89Q)
Variant1ClinVarID: 11922
Variant1CAID: CA256124
Variant2: c.972+2T>C (1060+2T>C)
Variant2ClinVarID: N/A
Variant2CAID: CA355962890
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
PKMPS1P2a
Case#: PKMPS1P2a, 8 years old (age at presentation), female, Pakastani
DiseaseAssertion: MPS-IH
FamilyInfo: Proband has an affected younger brother (PKMPS1P2b)
CasePresentingHPOs: On and off snoring, nasal congestion, failure to thrive, abdominal distension, recurrent respiratory infections, hepatomegaly (HP:0025267, HP:0001742, HP:0001508, HP:0003270, HP:0002788, HP:0002240)
CaseHPOFreeText: A liver span of 2 cm with firm consistency and a smooth surface. Smooth muscle infections.
CaseNotHPOs: Vomiting, headache (HP:0002013, HP:0002315)
CaseNotHPOFreeText: Fever, difficulty walking, normal facial features and normal eyes.
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.908T>C (p.L303P)
Variant1ClinVarID: N/A
Variant1CAID: CA355962537
Variant2: c.908T>C (p.L303P)
Variant2ClinVarID: N/A
Variant2CAID: CA355962537
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
9
Case#: Patient 9 (see Table 1), 5 years old - deceased (age at report), 1 year old (age at onset), female, height of 102 cm, weight of 18 kg, located at Mahdia: Touristic region.
DiseaseAssertion: MPS1 - severe
FamilyInfo: Parents were 1st cousins (see Table 2), aged 50 yrs (M) and 62 yrs (F).
CasePresentingHPOs: HP:0004322, HP:0010864, HP:0001537, HP:0000687, HP:0030812, HP:0001999, HP:0007957, HP:0000943 (Short stature, severe intellectual disability, umbilical hernia, widely spaced teeth, enlarged tonsils, facial dysmorphia, corneal clouding, dysostosis multiplex)
CaseHPOFreeText: Pigmented skin
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: IDUA activity 0.020 μKat/kg
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1882C>T (p.R628X)
Variant1ClinVarID: 550421
Variant1CAID: CA2802462
Variant2: c.1882C>T (p.R628X)
Variant2ClinVarID: 550421
Variant2CAID: CA2802462
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
4
Case#: Patient 4 (see Table 1), 9 years - deceased (age at report), 7 months (age at onset), male, height of 107 cm, weight of 19 kg, location at Gabes: Industrial region.
DiseaseAssertion: MPS1 - severe
FamilyInfo: One affected siblings (Patient 5), parents were 1st cousins (see Table 2) aged 55 yrs (M) and 65 yrs (F).
CasePresentingHPOs: HP:0004322, HP:0001999, HP:0000924, HP:0007957, HP:0001537, HP:0010864 (Short stature, abnormal facial shape, skeletal abnormality, corneal clouding, umbilical hernia, severe intellectual disability)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: IDUA activity: 0.018 μKat/kg
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1598C>G (p.P533R)
Variant1ClinVarID: 11910
Variant1CAID: CA256112
Variant2: c.1598C>G (p.P533R)
Variant2ClinVarID: 11910
Variant2CAID: CA256112
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Pt1
Case#: Pt1, Male, 20 months (diagnosis), 20 months (onset)
DiseaseAssertion: Hurler Syndrome
FamilyInfo: N/A Pedigree (Figure 4Pt1)
CasePresentingHPOs: HP:0000280, HP:0007957, HP:0001654, HP:0100814, (Coarse face, Cornea clouding, Valvular heart disease, Dermal melanocytosis)
CaseHPOFreeText: N/A
CaseNotHPOs: HP:0001387, HP:0000365, HP:0001433, (Joint stiffness, Hearing loss, Hepatosplenomegaly)
CaseNotHPOFreeText: Long bone deformation, Spinal deformation, Inguinal or umbilical hernia
CaseEnzymeAssay: α-L-iduronidase 0.17 (dried blood spots, normal >1.32 µM/h)
CaseUrineGAGs: Urine heparan sulfate 8.26 (mg/mmol creatinine) {<0.67}
CaseERT: N/A
CaseBMT: N/A
GenotypingMethod: Not Provided.
Variant1: c.1190-10C>A
Variant1ClinVarID: 950888
Variant1CAID: CA1139658405
Variant2: c.1190-10C>A
Variant2ClinVarID: 950888
Variant2CAID: CA1139658405
AdditionalVariants: N/A
ParentalGenotype: Both parents are homozygous for not having the c.1190-10C>A variant (figure 4 Pt 1)
PreviouslyPublished: N/A
8-year-old girl
Case#: Female, 6 years old (age of onset), 8 years old (age at report). Developmentally normal at 6 years old but had a 1-year long history of painful and stiff joints. Her weight was in the 5th percentile, height in the 3rd percentile, and head circumference in the 10th percentile for her age group.
DiseaseAssertion: MPS1-S
FamilyInfo: The patient's parents are second cousins. She has two healthy brothers.
CasePresentingHPOs: Joint stiffness, recurrent otitis media, snoring, joint contractures, carpal tunnel syndrome (HP:0001387, HP:0000403, HP:0025267, HP:0100790, HP:0012185)
CaseHPOFreeText: Painful joints affecting the hands, wrists, knees, elbows, and shoulders. At 8 years old, she had second and third finger numbness. Flexion contractures in distal and proximal interphalangeal joints, wrists, and restricted joint mobility was observed. Echocardiogram showed thickening of the mitral and aortic valves, and brain magnetic resonance imaging demonstrated increased signal in the white matter surrounding dilated perivascular spaces.
CaseNotHPOs: Coarse facial features, cardiac murmurs, hernias (HP:0000256, HP:0030148, HP:0100790)
CaseNotHPOFreeText: Organomegaly
CaseEnzymeAssay: 1 nmol/h/mg (reference range, 14-41 nmol/h/mg)
CaseUrineGAGs: Excess heparan and dermatan sulfate
CaseERT: Enzyme replacement therapy was initiated. Improvements in hand mobility and joint size were noted, as well as less joint discomfort.
CaseBMT: N/A
Variant1: c.1039A>C (p.S347R)
Variant1ClinVarID: 1067172
Variant1CAID: CA355963126
Variant2: c.1039A>C (p.S347R)
Variant2ClinVarID: 1067172
Variant2CAID: CA355963126
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Two novel mutations causing mucopolysaccharidosis type I detected by single strand conformational analysis of the alpha-L-iduronidase gene
annotating here sice the article is only available as a PDF.
Case#: Clarke Patient 3
DiseaseAssertion: MPS I, severe
FamilyInfo: father and mother were het carriers
CasePresentingHPOs:
CaseHPOFreeText: severe clinical phenotype with presentation in the first year of life and currently at age two has received bone marrow transplantation
CaseNotHPOs:
CaseNotHPOFreeText:
GenotypingMethod: SSCP, restriction enzyme digestion
PreviouslyPublished: n/a
Variant: c.820G>T (p.Glu274Ter); Q70X phase confirmed
CAID: CA355962341
SupplementalData: n/a
Novel frameshift variant in the IDUA gene underlies Mucopolysaccharidoses type I in a consanguineous Yemeni pedigree
PMID: 28649516
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
207
Case#: 207 5.9 yrs male, age at initial diagnosis 2.6 yrs DiseaseAssertion: MPS IH FamilyInfo:Nil CasePresentingHPOs: CaseHPOFreeText: CaseNotHPOs: CaseNotHPOFreeText: CaseEnzymeAssay: IDUA activity: low leukocyte IDUA enzyme activity CaseUrineGAGs: CaseERT: 3 yrs on ERT, then study drug, valanafusp alpha, also called AGT-181 for 12 months
CaseBMT: No PreviouslyPublished Don't know Variant1:p.Q70X Variant1ClinVarID: 11909 Variant1CAID: CA204563 Variant2:p.W402X Variant2ClinVarID: 11908 Variant2CAID: CA220498
Hurler disease
Case#: Patient 50, 2 years old (age at report), female, Indian
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: Coarse facial features, hepatosplenomegaly, corneal clouding, recurrent infections, hernia (HP:0000280, HP:0001433, HP:0007957, HP:0002719, HP:0100790)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 2.2% (Range of residual enzyme activity: 0.0%-4.8%)
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.238G>T (p.Val80Phe)
Variant1ClinVarID: N/A
Variant1CAID: CA355946451
Variant2: c.784delC (p.His262Thrfs*55)
Variant2ClinVarID: 956890
Variant2CAID: CA2802083
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Hurler disease
Case#: Patient 10, 1 years old (age at report), male, Indian
DiseaseAssertion: MPS1-H
FamilyInfo: Sibling of patient 11
CasePresentingHPOs: Coarse facial features, recurrent infections, dysostosis multiplex, intellectual disability, hernia (HP:0000280, HP:0002719, HP:0000943, HP:0001249, HP:0100790)
CaseHPOFreeText: Cardiac disease
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 2.7% (Range of residual enzyme activity: 0.0%-4.8%)
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.531C>G (p.Phe177Leu)
Variant1ClinVarID: 2432729
Variant1CAID: CA2801983
Variant2: c.531C>G (p.Phe177Leu)
Variant2ClinVarID: 2432729
Variant2CAID: CA2801983
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Hurler disease
Case#: Patient 30, 8 years old (age at report), male, Indian
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: Coarse facial features, hepatosplenomegaly, joint contractures, corneal clouding, recurrent infections, dysostosis multiplex, intellectual disability (HP:0000280, HP:0001433, HP:0002828, HP:0007957, HP:0002719, HP:0000943, HP:0001249)
CaseHPOFreeText: Cardiac disease
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 2.7% (Range of residual enzyme activity: 0.0%-4.8%)
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1373T>C (p.Leu458Pro)
Variant1ClinVarID: N/A
Variant1CAID: CA355964255
Variant2: c.1373T>C (p.Leu458Pro)
Variant2ClinVarID: N/A
Variant2CAID: CA355964255
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Hurler disease
Case#: Patient 51, 2 years old (age at report), female, Indian
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: Coarse facial features, hepatosplenomegaly, joint contractures, dysostosis multiplex (HP:0000280, HP:0001433, HP:0002828, HP:0000943)
CaseHPOFreeText: Cardiac disease
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 2.4% (Range of residual enzyme activity: 0.0%-4.8%)
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.265G>C in the article - incorrect variant but unknown what the correct nomenclature is. Could be c.265C>G (p.Arg89Gly) or c.266G>C (p.Arg89Pro)
Variant1ClinVarID: N/A
Variant1CAID: N/A
Variant2: c.779C>T (p.Ser260Phe)
Variant2ClinVarID: 3895951
Variant2CAID: CA355962251
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
missense mutations
Case#: Patient 82, Turkey
DiseaseAssertion: MPS1-S
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1469T>C (p.L490P)
Variant1ClinVarID: 11919
Variant1CAID: CA220503
Variant2: c.1469T>C (p.L490P)
Variant2ClinVarID: 11919
Variant2CAID: CA220503
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
missense mutations
Case#: Patient 10, Italy
DiseaseAssertion: MPS1-H/S
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.1603C>T (p.L535F)
Variant2ClinVarID: 638076
Variant2CAID: CA355865038
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
missense mutations
Case#: Patient 65, Spain
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.979G>C (p.A327P)
Variant1ClinVarID: 167190
Variant1CAID: CA234128
Variant2: c.1154C>G (p.P385R)
Variant2ClinVarID: 556024
Variant2CAID: CA355963438
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Case#: Variant not associated with a proband. Variant listed in supplementary materials in Supplementary Table 4
DiseaseAssertion: Mucopolysaccharidosis type I, MPS I
FamilyInfo: N/A
CasePresentingHPOs:
CaseHPOFreeText:
CaseNotHPOs:
CaseNotHPOFreeText:
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: H82Q
Variant1ClinVarID:
Variant1CAID: CA355946477
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished: N/A
Case#: Variant not associated with a proband. Variant listed in supplementary materials in Supplementary Table 4
DiseaseAssertion: Mucopolysaccharidosis type I, MPS I
FamilyInfo: N/A
CasePresentingHPOs:
CaseHPOFreeText:
CaseNotHPOs:
CaseNotHPOFreeText:
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: M133I
Variant1ClinVarID:
Variant1CAID: CA91166179
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished: N/A
Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome)
PMID: 21037085
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
Hurler phenotype in a patient
Case#: 22-month-old Norwegian female patient
DiseaseAssertion: MPS-H
FamilyInfo: Mother and father received parental testing.
CasePresentingHPOs: Joint stiffness (HP:0001387)
CaseHPOFreeText: She had a tendency to fall without normal protective reactions. Typical facial appearance and other clinical findings were suggestive of MPS I Hurler, and this diagnosis was also supported by X-ray images which showed characteristic skeletal changes. Motor development appeared slightly delayed, while intellectual development was considered to be normal.
CaseNotHPOs: Corneal clouding (HP:0007957)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 0.006 μmol phenol/18 h/mg protein. Normal range of IDUA activity (n = 52, healthy volunteers): 0.143–0.351 μmol phenol/18 h/mg protein.
CaseUrineGAGs: Urinary GAG excretion - 101 mg GAG/mmol creatinine. The patient demonstrated increased excretion of GAGs, which were identified as HS and DS. Normal age adjusted range of urinary GAG excretion: 14–34 mg GAG/mmol creatinine.
CaseERT: The patient was initiated on enzyme replacement therapy (ERT) with weekly infusions of recombinant α-l-iduronidase 100 IE/kg
CaseBMT: The patient successfully received hematopoietic stem cell transplantation (HSCT) 4 months after ERT.
Variant1: c.1727+3G>C
Variant1ClinVarID: 4817926
Variant1CAID: CA91171181
Variant2: c.208C>T (p.Q70X)
Variant2ClinVarID: 11909
Variant2CAID: CA204563
AdditionalVariants: N/A
ParentalGenotype: Mother: c.208C>T (p.Q70X); 0.071 μmol phenol/18 h/mg protein (IDUA activity). Father: c.1727+3G>C; 0.079 μmol phenol/18 h/mg protein (IDUA activity).
PreviouslyPublished N/A
Successful pregnancy and breastfeeding in a woman with mucopolysaccharidosis type I while receiving laronidase enzyme replacement. therapy
PMID: 25864295
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
8
Case#: Patient 8, male
DiseaseAssertion: MPS I
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: Low IDUA enzyme activity 1.50 (Ref. 4.87 ~ 54.70 μmol/g protein/h)
CaseUrineGAGs: Negative GAG tests
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1081G>A (p.A361T)
Variant1ClinVarID: 92624
Variant1CAID: CA145865
Variant2: c.1395delC (p.G466Afs*?)
Variant2ClinVarID: 929236
Variant2CAID: CA549264595
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Epidemiology of Mucopolysaccharidoses Update
PMID: 33578874
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
43/M
Case#: Patient 43, male, Han origin, 5 years old (age at diagnosis)
DiseaseAssertion: MPS1-H/S
FamilyInfo: N/A
CasePresentingHPOs: Joint stiffness, Mongolian macula, Hepatosplenomegaly, Hernia, Airway obstruction (HP:0001387, HP:0011369, HP:0001433, HP:0100790, HP:0006536)
CaseHPOFreeText: N/A
CaseNotHPOs: Global Developmental Delay, Macrocephaly (HP:0001263, HP:0000256)
CaseNotHPOFreeText: Cardiac disease
CaseEnzymeAssay: IDUA activity 1.5 nmol/h/mg protein. The normal range in Chinese controls was found to be 27.2–52 nmol/h/mg protein.
CaseUrineGAGs: Diagnosis was confirmed biochemically by the demonstration of an increased excretion of urinary dermatan sulfate and heparan sulfate.
CaseERT: N/A
CaseBMT: N/A
Variant1: c.300-3C>G
Variant1ClinVarID: 551563
Variant1CAID: CA549265042
Variant2: c.530dupT (p.Glu178ArgfsTer5) (Paper refers to the variant as c.531dupT, there is a typo in the article where all duplication variants are one base pair off)
Variant2ClinVarID: N/A
Variant2CAID: CA2586973520
AdditionalVariants: c.1037T>G (p.L346R)
ParentalGenotype: The transmission of sequence variations found in each patient was inferred by sequencing the corresponding exons of the patient's parents - confirmed in trans by parental testing.
PreviouslyPublished N/A
Abnormal
Case#: No additional case information provided.
DiseaseAssertion: Not specified
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: Abnormal
CaseUrineGAGs: Normal
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1148G>A (p.R383H)
Variant1ClinVarID: 558189
Variant1CAID: CA2802205
Variant2: c.112C>A (p.R89S)
Variant2ClinVarID: 2432781
Variant2CAID: CA355945526
AdditionalVariants: c.250G>A (p.G48S), ClinVarID:726495, CAID:CA2801152
ParentalGenotype: N/A
PreviouslyPublished N/A
Abnormal
Case#: No additional case information provided
DiseaseAssertion: MPSI-H/S
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: Abnormal
CaseUrineGAGs: Normal
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11909
Variant1CAID: CA220498
Variant2: c.1577T>C (p.L526P)
Variant2ClinVarID: 567566
Variant2CAID: CA2802300
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
15
Case#: Patient 15 (see Table 2), 38 weeks, 1 day (Gestational age)
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: Inguinal hernia (HP:0000023)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 0.23 nmol x mg-1 × hr-1
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.494-1G > A
Variant1ClinVarID: 557942
Variant1CAID: CA355961634
Variant2: c.494-1G > A
Variant2ClinVarID: 557942
Variant2CAID: CA355961634
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
26
Case#: Patient 26, male, 1 year (age at presentation).
DiseaseAssertion: MPS1-H
FamilyInfo: Consanguinity in the family not present for this patient.
CasePresentingHPOs: Corneal clouding, coarse facial features, dysostosis multiplex, hepatomegaly, intellectual disabilities, splenomegaly (HP:0007957, HP:0000256, HP:0000943, HP:0002240, HP:0010864, HP:0001744)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1855C>T (p.R619X)
Variant1ClinVarID: 280976
Variant1CAID: CA2802455
Variant2: c.1855C>T (p.R619X)
Variant2ClinVarID: 280976
Variant2CAID: CA2802455
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
108 MOR.V. 0,01 DBS NM_000203.5:c.[208C>T];[1029C>A] Severe C
Case#: Patient 108, Central district of the Russian Federation
DiseaseAssertion: MPS1, Severe
FamilyInfo:
CasePresentingHPOs:
CaseHPOFreeText: IdA activity in DBS=0,01 DBS, severe phenotype, hyperexcretion of urine heparan and dermatan sulfate
CaseNotHPOs:
CaseNotHPOFreeText:
CasePreviousTesting: Electrophoresis of urine GAGs and measurement of lysosomal enzyme activity in peripheral blood leukocytes or DBSs were performed for all patients with suspected MPS I
GenotypingMethod: The 14 exons and exon–intron boundaries of the IDUA gene were amplified from DNA samples. Sanger sequencing of each one of the 14 exons was performed. PCR products containing mutations were re-sequenced in both directions. The mutations were further confirmed where possible by restriction analysis (data not shown).
PreviouslyPublished:
Variant: NM_000203.5:c.[208C>T];[1029C>A]
ClinVar: 222997
CAID: CA356984
SupplementalData: n/a
10 MPS I patients
Case#: MPS 1 patient
DiseaseAssertion: N/A
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.1650+5G>A
Variant2ClinVarID: 92634
Variant2CAID: CA220504
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Anthropometric data of 14 patients with mucopolysaccharidosis I: retrospective analysis and efficacy of recombinant human alpha-L-iduronidase (laronidase)
PMID: 19783188
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
7
Case#: Patient 7, born in 2005 (paper published in 2017), 16 months (age at first treatment)
DiseaseAssertion: MPSI-H
FamilyInfo: N/A
CasePresentingHPOs: Corneal clouding (HP:0007957)
CaseHPOFreeText: N/A
CaseNotHPOs: Retinopathy, cataract (HP:0000488, HP:0000518)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 62.57 ng/mol (34.3 weight matched enzyme reference assay)
CaseUrineGAGs: 0.59 DS/CS
CaseERT: No
CaseBMT: Yes, Cord
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.386-2A>G
Variant2ClinVarID: 222994
Variant2CAID: CA356991
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
2
Case#: Patient 2, born in 2000 (paper published in 2017), 18 months (age at first treatment)
DiseaseAssertion: MPSI-H
FamilyInfo: N/A
CasePresentingHPOs: Corneal clouding (HP:0007957)
CaseHPOFreeText: N/A
CaseNotHPOs: Retinopathy, cataract (HP:0000488, HP:0000518)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 28 ng/mol (38 weight matched enzyme reference assay)
CaseUrineGAGs: 0.36 DS/CS
CaseERT: No
CaseBMT: Yes, MUD
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.979G>C (p.A327P)
Variant2ClinVarID: 167190
Variant2CAID: CA234128
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Agreement between the results of meta-analyses from case reports and from clinical studies regarding the efficacy of laronidase therapy in patients with mucopolysaccharidosis type I who initiated enzyme replacement therapy in adult age: An example of case reports meta-analyses as an useful tool for evidence-based medicine in rare diseases
Free, full-text NOT available. Full text was retrieved via a university account, and the free PubMed abstract was annotated.
This paper describes a meta-analysis of previously published data for 11 patients. PMID's for prior published reports:
25864295, 21482163, 22303797, 21167740, 19894140, 18792977, 18546328, 16601901
The above PMID's are all included in the IDUA Excel file.
Three cited manuscripts do not have a PMID and are not included in the IDUA Excel file. Links to these papers are provided below:
https://doi.org/10.1016/j.farma.2010.11.005 (in Spanish)
1
Case#: Patient 1 (see Table 2), female, 18.6 years old (age at report), 5.9 years (years of treatment), 6 surgeries.
DiseaseAssertion: MPS1-HS
FamilyInfo: N/A
CasePresentingHPOs: HP:0002176, HP:0002360 (Spinal cord compression, sleep abnormality)
CaseHPOFreeText: Psychiatric problems
CaseNotHPOs: HP:0000238 (Hydrocephalus)
CaseNotHPOFreeText: Shunt Placement
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: Yes
CaseBMT: N/A
Variant1: c.712T>A (p.L238Q) CDNA and protein change do not match. Known variant p.L238Q has a CDNA change of c.713T>A.
Variant1ClinVarID: 265418
Variant1CAID: CA2802065
Variant2: c.63delC (p.P22Rfs*86) Known HGVS nomenclature is c.65del as there is a run of 5 C's.
Variant2ClinVarID: 929238
Variant2CAID: CA437911597
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Mutational Analysis of the alpha-L-iduronidase gene in three Egyptian families: identification of three novel mutations and five novel polymorphisms
PMID: 19839758
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
older sibling
Case#: OS of sibship 7, female, 4.3 years old (age at diagnosis), 4.5 years old (age at ERT enrollment), 5.5 years (duration of ERT)
DiseaseAssertion: MPS1-HS
FamilyInfo: Affected YS (YS of sibship 7)
CasePresentingHPOs: HP:0007957, HP:0000943, HP:0002828, HP:0001263, HP:0001270 (Corneal opacity, dysostosis, joint contractures, cognitive impairment, motor impairment)
CaseHPOFreeText: Cardiac disease, somatic impairment
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: Yes - After 5 years of ERT, cardiac symptoms stabilized, and musculoskeletal symptoms, motor development, and corneal clouding progressed.
CaseBMT: N/A
Variant1: c.1598C>G (p.P533R)
Variant1ClinVarID: 11910
Variant1CAID: CA256112
Variant2: (L564fsx) No CDNA change provided.
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
MPS IH patients
Case#: Patient 3
DiseaseAssertion: MPS1
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.208C>T (p.Q70X)
Variant1ClinVarID: 11909
Variant1CAID: CA204563
Variant2: c.1487C>G (p.P496R)
Variant2ClinVarID: 496861
Variant2CAID: CA2802275
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler Syndrome
PMID: 34788506
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
Molecular characterization of a large cohort of Mucopolysaccharidosis patients: Iran Mucopolysaccharidosis RE-diagnosis Study (IMPRESsion)
PMID: 35005816
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
5 Hurler/Scheie
Case#: Family 21, Pakistan
DiseaseAssertion: MPS1-H/S
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: The α-L-iduronidase enzyme activities in leucocytes from all patients in the study was measured using the artificial substrate 4-methylumbelliferyl α-L iduronide (Sigma). Values ranged from 0 to 2.47 nmol/h/mg protein (reference range: 28–92 nmol/h/mg protein) and did not correlate to the clinical phenotype.
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1469T>C (p.L490P)
Variant1ClinVarID: 11919
Variant1CAID: CA220503
Variant2: c.1469T>C (p.L490P)
Variant2ClinVarID: 11919
Variant2CAID: CA220503
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
High Precision Newborn Screening for Mucopolysaccharidosis Type I by Enzymatic Activity followed by Endogenous, Non-Reducing End Glycosaminoglycan Analysis
PMID: 39645522
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
CaseMYH7-8: Japan, Asian
CasePresentingHPOs: HP:0001639, HP:0006685 (Hypertrophic cardiomyopathy, Endomyocardial fibrosis)
HPOsFreeText: N/A
CaseNotHPOs: N/A
NotHPOsFreeText: N/A
CaseAddInfo:
CaseGenotypingMethod: Genomic DNA was extracted from whole blood from each proband. They each had 95 genes associated with DCM, HCM, and other inherited cardiovascular diseases sequenced with a panel, including both the exons and spicing regions. Variants were then filtered for rarity and pathogenicity.
Variant: NM_000257.3:c.1357C>T (p.Arg453Cys)
ClinVar: 14089 https://www.ncbi.nlm.nih.gov/clinvar/variation/14089/
gnomAD: Not in gnomAD
CaseMYH7-7: Japan, Asian
CasePresentingHPOs: HP:0001639, HP:0006685 (Hypertrophic cardiomyopathy, Endomyocardial fibrosis)
HPOsFreeText: N/A
CaseNotHPOs: N/A
NotHPOsFreeText: N/A
CaseAddInfo:
CaseGenotypingMethod: Genomic DNA was extracted from whole blood from each proband. They each had 95 genes associated with DCM, HCM, and other inherited cardiovascular diseases sequenced with a panel, including both the exons and spicing regions. Variants were then filtered for rarity and pathogenicity.
Variant: NM_000257.3:c.1358G>A (p.Arg453His)
ClinVar: 42838 https://www.ncbi.nlm.nih.gov/clinvar/variation/42838/
gnomAD: Not in gnomAD
CaseMYH7-9: Japan, Asian
CasePresentingHPOs: HP:0001639, HP:0006685 (Hypertrophic cardiomyopathy, Endomyocardial fibrosis)
HPOsFreeText: N/A
CaseNotHPOs: N/A
NotHPOsFreeText: N/A
CaseAddInfo:
CaseGenotypingMethod: Genomic DNA was extracted from whole blood from each proband. They each had 95 genes associated with DCM, HCM, and other inherited cardiovascular diseases sequenced with a panel, including both the exons and spicing regions. Variants were then filtered for rarity and pathogenicity.
Variant: NM_000257.3:c.1012G>A (p.Val338Met)
ClinVar: 164381 https://www.ncbi.nlm.nih.gov/clinvar/variation/164381/
gnomAD: Not in gnomAD
Case153: Female, 0.083 years onset, Japan, Asian
DiseaseAssertion: Left ventricular noncompaction
CasePresentingHPOs: HP:0030682, HP:0025169 (Left ventricular noncompaction, Left ventricular systolic dysfunction)
HPOsFreeText: Left Ventricular Ejection Fraction at 46%, LVDD-Z score at 0.795
CaseNotHPOs: HP:0011675 (Arrhythmia)
NotHPOsFreeText: Congenital heart disease with significant hemodynamic changes
CaseAddInfo: Sister also has LVNC
CasePreviousTesting: Genes tested include the 8 sarcomere genes as well as 65 more listed in Table S1.
CaseGenotypingMethod: Genomic DNA was extracted from whole blood from each of the probands. Next Generation Sequencing of 73 genes related to cardiac function was performed, incorporating PCR amplification, and any variants found were subjected to filtering for frequency and pathogenicity. Any variants suggested to be pathogenic were confirmed by Sanger sequencing afterwards.
Variant: NM_000257.3:c.1342G>A (p.Glu448Lys)
CAID: CA389050830 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000257.3:c.1342G%3EA
gnomAD: Not in gnomAD
Case361: Female, Birth onset, Japan, Asian
DiseaseAssertion: Left ventricular noncompaction
CasePresentingHPOs: HP:0030682, HP:0025169, HP:0001635 (Left ventricular noncompaction, Left ventricular systolic dysfunction, Heart failure)
HPOsFreeText: Left Ventricular Ejection Fraction at 38%, LVDD-Z score at 0.977
CaseNotHPOs: HP:0011675 (Arrhythmia)
NotHPOsFreeText: Congenital heart disease with significant hemodynamic changes
CaseAddInfo: No family history
CasePreviousTesting: Genes tested include the 8 sarcomere genes as well as 65 more listed in Table S1.
CaseGenotypingMethod: Genomic DNA was extracted from whole blood from each of the probands. Next Generation Sequencing of 73 genes related to cardiac function was performed, incorporating PCR amplification, and any variants found were subjected to filtering for frequency and pathogenicity. Any variants suggested to be pathogenic were confirmed by Sanger sequencing afterwards.
Variant: NM_000257.3:c.896-1G>A
CAID: CA389051805 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000257.3%3Ac.896-1G%3EA
gnomAD: Not in gnomAD
Case333: Male, Birth onset, Japan, Asian
DiseaseAssertion: Left ventricular noncompaction
CasePresentingHPOs: HP:0030682, HP:0025169, HP:0001635 (Left ventricular noncompaction, Left ventricular systolic dysfunction, Heart failure)
HPOsFreeText: Left Ventricular Ejection Fraction at 10%, LVDD-Z score at -0.4
CaseNotHPOs: HP:0011675 (Arrhythmia)
NotHPOsFreeText: Congenital heart disease with significant hemodynamic changes
CaseAddInfo: No family history
CasePreviousTesting: Genes tested include the 8 sarcomere genes as well as 65 more listed in Table S1.
CaseGenotypingMethod: Genomic DNA was extracted from whole blood from each of the probands. Next Generation Sequencing of 73 genes related to cardiac function was performed, incorporating PCR amplification, and any variants found were subjected to filtering for frequency and pathogenicity. Any variants suggested to be pathogenic were confirmed by Sanger sequencing afterwards.
Variant: NM_000257.3:c.668C>T (p.Ala223Val)
CAID: CA389052292 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000257.3:c.668C%3ET
gnomAD: Not in gnomAD
Case250: Male, 0.04 years onset, Japan, Asian
DiseaseAssertion: Left ventricular noncompaction
CasePresentingHPOs: HP:0030682, HP:0001635 (Left ventricular noncompaction, Heart failure)
HPOsFreeText: Left Ventricular Ejection Fraction at 60%, LVDD-Z score at 1.6326
CaseNotHPOs: HP:0011675 (Arrhythmia)
NotHPOsFreeText: Congenital heart disease with significant hemodynamic changes
CaseAddInfo: No family history
CasePreviousTesting: Genes tested include the 8 sarcomere genes as well as 65 more listed in Table S1.
CaseGenotypingMethod: Genomic DNA was extracted from whole blood from each of the probands. Next Generation Sequencing of 73 genes related to cardiac function was performed, incorporating PCR amplification, and any variants found were subjected to filtering for frequency and pathogenicity. Any variants suggested to be pathogenic were confirmed by Sanger sequencing afterwards.
Variant: NM_000257.3:c.2030A>T (p.Glu677Val)
CAID: CA389049283 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000257.3:c.2030A%3ET
gnomAD: Not in gnomAD
Case427: Female, 1.5 years onset, Japan, Asian
DiseaseAssertion: Left ventricular noncompaction
FamilyInfo: Father has DCM
CasePresentingHPOs: HP:0030682, HP:0025169 (Left ventricular noncompaction, Left ventricular systolic dysfunction)
HPOsFreeText: Left Ventricular Ejection Fraction at 44.1%, LVDD-Z score at 1.3709
CaseNotHPOs: HP:0011675, HP:0001635 (Arrhythmia, Heart failure)
NotHPOsFreeText: Congenital heart disease with significant hemodynamic changes
CaseAddInfo:
CasePreviousTesting: Genes tested include the 8 sarcomere genes as well as 65 more listed in Table S1.
CaseGenotypingMethod: Genomic DNA was extracted from whole blood from each of the probands. Next Generation Sequencing of 73 genes related to cardiac function was performed, incorporating PCR amplification, and any variants found were subjected to filtering for frequency and pathogenicity. Any variants suggested to be pathogenic were confirmed by Sanger sequencing afterwards.
Variant: NM_000257.3:c.2821C>T (p.Arg941Cys)
CAID: CA389046936 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000257.3:c.2821C%3ET
gnomAD: Not in gnomAD
Case392: Male, 0.083 years onset, Japan, Asian
DiseaseAssertion: Left ventricular noncompaction
CasePresentingHPOs: HP:0030682, HP:0025169, HP:0001635 (Left ventricular noncompaction, Left ventricular systolic dysfunction, Heart failure)
HPOsFreeText: Left Ventricular Ejection Fraction at 29%, LVDD-Z score at 2.1428
CaseNotHPOs: HP:0011675 (Arrhythmia)
NotHPOsFreeText: Congenital heart disease with significant hemodynamic changes
CaseAddInfo: No family history
CasePreviousTesting: Genes tested include the 8 sarcomere genes as well as 65 more listed in Table S1.
CaseGenotypingMethod: Genomic DNA was extracted from whole blood from each of the probands. Next Generation Sequencing of 73 genes related to cardiac function was performed, incorporating PCR amplification, and any variants found were subjected to filtering for frequency and pathogenicity. Any variants suggested to be pathogenic were confirmed by Sanger sequencing afterwards.
Variant: NM_000257.3:c.944A>G (p.Gln315Arg)
CAID: CA389051698 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000257.3:c.944A%3EG
gnomAD: Not in gnomAD
Case378: Female, Birth onset, Japan, Asian
DiseaseAssertion: Left ventricular noncompaction
FamilyInfo: Sister has LVNC
CasePresentingHPOs: HP:0030682, HP:0025169, HP:0001635, HP:0005110 (Left ventricular noncompaction, Left ventricular systolic dysfunction, Heart failure, Atrial fibrillation)
HPOsFreeText: Left Ventricular Ejection Fraction at 20%, LVDD-Z score at 0.1
CaseNotHPOs: N/A
NotHPOsFreeText: Congenital heart disease with significant hemodynamic changes
CaseAddInfo:
CasePreviousTesting: Genes tested include the 8 sarcomere genes as well as 65 more listed in Table S1.
CaseGenotypingMethod: Genomic DNA was extracted from whole blood from each of the probands. Next Generation Sequencing of 73 genes related to cardiac function was performed, incorporating PCR amplification, and any variants found were subjected to filtering for frequency and pathogenicity. Any variants suggested to be pathogenic were confirmed by Sanger sequencing afterwards.
Variant: NM_000257.3:c.1859T>C (p.Leu620Pro)
CAID: CA389049669 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000257.3:c.1859T%3EC
gnomAD: Not in gnomAD
Case298: Female, 6 years onset, Japan, Asian
DiseaseAssertion: Left ventricular noncompaction
CasePresentingHPOs: HP:0030682 (Left ventricular noncompaction)
HPOsFreeText: Left Ventricular Ejection Fraction at 65%, LVDD-Z score at 2.1
CaseNotHPOs: HP:0011675 (Arrhythmia)
NotHPOsFreeText: Congenital heart disease with significant hemodynamic changes
CaseAddInfo: No family history
CasePreviousTesting: Genes tested include the 8 sarcomere genes as well as 65 more listed in Table S1.
CaseGenotypingMethod: Genomic DNA was extracted from whole blood from each of the probands. Next Generation Sequencing of 73 genes related to cardiac function was performed, incorporating PCR amplification, and any variants found were subjected to filtering for frequency and pathogenicity. Any variants suggested to be pathogenic were confirmed by Sanger sequencing afterwards.
Variant: NM_000257.3:c.2710C>T (p.Arg904Cys)
ClinVar: 164316 https://www.ncbi.nlm.nih.gov/clinvar/variation/164316/
gnomAD: Ashkenazi Jewish 9.921e-5, Overall 3.977e-6 https://gnomad.broadinstitute.org/variant/14-23893328-G-A
7
Case7: Female, 13 years diagnosis, China, Asian
DiseaseAssertion: Hypertrophic Cardiomyopathy
CasePresentingHPOs: HP:0001639, HP:0001667, HP:0001279 (Hypertrophic cardiomyopathy, Right ventricular hypertrophy, Syncope)
HPOsFreeText: 2 SCD risk factors, NYHA class is II, Right ventricular wall thickness 12 mm
CaseNotHPOs: HP:0002092, HP:0001642, HP:0030680, HP:0011675 (Pulmonary arterial hypertension, Pulmonary stenosis, Congenital heart disease, Arrhythmia)
NotHPOsFreeText: N/A
CaseAddInfo: N/A
CaseGenotypingMethod: Probands' genomic DNA was extracted from blood samples. WES was performed, with the resulting sequence data mapped to a reference genome and variants filtered for pathogenicity and predicted effects. All variants identified were confirmed via Sanger sequencing of the respective genes.
Variant reported as below, but no SNP corresponds to the variant.
Variant: NP_000248.2:p.R719E
ClinVar: N/A
gnomAD: N/A
MultipleGeneVariants:
MYOM1 Variant:
Variant: NM_003803.3:c.2507G>T (p.Gly836Val)
CAID: CA8874590 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_003803.3:c.2507G%3ET
gnomAD: East Asian 5.044e-4, Overall 3.707e-5 https://gnomad.broadinstitute.org/variant/18-3129517-C-A
AKAP9 Variant:
Variant: NM_005751.4:c.11590T>C (p.Cys3864Arg)
CAID: CA368165252 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_005751.4:c.11590T%3EC
gnomAD: Not in gnomAD
1
Case1: Male, 27 years diagnosis, China, Asian
DiseaseAssertion: Hypertrophic Cardiomyopathy
CasePresentingHPOs: HP:0001639, HP:0001667 (Hypertrophic cardiomyopathy, Right ventricular hypertrophy)
HPOsFreeText: 0 SCD risk factors, NYHA class is I, Right ventricular wall thickness 13 mm
CaseNotHPOs: HP:0002092, HP:0001642, HP:0030680, HP:0011675 (Pulmonary arterial hypertension, Pulmonary stenosis, Congenital heart disease, Arrhythmia)
NotHPOsFreeText: N/A
CaseAddInfo: N/A
CaseGenotypingMethod: Probands' genomic DNA was extracted from blood samples. WES was performed, with the resulting sequence data mapped to a reference genome and variants filtered for pathogenicity and predicted effects. All variants identified were confirmed via Sanger sequencing of the respective genes.
Variant listed as MYH7-478N. Typo is suspected, below is the entry for MYH7-I478N, the actual variant at this location
Variant: NM_000257.3:c.1433T>A (p.Ile478Asn)
CAID: CA389050614 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000257.3:c.1433T%3EA
gnomAD: Not in gnomAD
MultipleGeneVariants:
TTN Variants:
Unknown Variant
Variant1: TTN-S3872fs
CAID: N/A
gnomAD: N/A
Unknown Variant
Variant2: TTN-S6350A
CAID: N/A
gnomAD: N/A
Unknown Variant
Variant3: TTN-P10663R
CAID: N/A
gnomAD: N/A
ACTN2 Variant
Unknown Variant
Variant: ACTN2-P32fs
CAID: N/A
gnomAD: N/A
CaseMYH7-21: Australia
DiseaseAssertion: Hypertrophic Cardiomyopathy
FamilyInfo: N/A
CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)
HPOsFreeText: N/A
CaseNotHPOs: N/A
NotHPOsFreeText: N/A
CaseAddInfo: 1 other proband shares this genotype
CasePreviousTesting: See Table 1
CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.
Variant: NM_000257.3:c.2389G>A (p.Ala797Thr)
ClinVar: 42901 https://www.ncbi.nlm.nih.gov/clinvar/variation/42901/
gnomAD: African 1.230e-4, Overall 2.386e-5 https://gnomad.broadinstitute.org/variant/14-23894525-C-T
CaseMYH7-34: Australia
DiseaseAssertion: Hypertrophic Cardiomyopathy
FamilyInfo: N/A
CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)
HPOsFreeText: N/A
CaseNotHPOs: N/A
NotHPOsFreeText: N/A
CaseAddInfo: N/A
CasePreviousTesting: See Table 1
CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.
Variant: NM_000257.3:c.1370T>C (p.Ile457Thr)
ClinVar: 42840 https://www.ncbi.nlm.nih.gov/clinvar/variation/42840/
gnomAD: European (Non-Finnish) 8.790e-6, Overall 3.976e-6 https://gnomad.broadinstitute.org/variant/14-23898201-A-G
CaseMYH7-25: Australia
DiseaseAssertion: Hypertrophic Cardiomyopathy
FamilyInfo: N/A
CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)
HPOsFreeText: N/A
CaseNotHPOs: N/A
NotHPOsFreeText: N/A
CaseAddInfo: 1 other proband shares this genotype
CasePreviousTesting: See Table 1
CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.
Variant: NM_000257.3:c.2207T>C (p.Ile736Thr)
ClinVar: 164342 https://www.ncbi.nlm.nih.gov/clinvar/variation/164342/
gnomAD: Not in gnomAD
CaseMYH7-28: Australia
DiseaseAssertion: Hypertrophic Cardiomyopathy
FamilyInfo: N/A
CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)
HPOsFreeText: N/A
CaseNotHPOs: N/A
NotHPOsFreeText: N/A
CaseAddInfo: N/A
CasePreviousTesting: See Table 1
CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.
Variant: NM_000257.3:c.2155C>T (p.Arg719Trp)
ClinVar: 14104 https://www.ncbi.nlm.nih.gov/clinvar/variation/14104/
gnomAD: European (Non-Finnish) 6.481e-5, Overall 3.185e-5 https://gnomad.broadinstitute.org/variant/14-23895180-G-A
CaseMYH7-36: Australia
DiseaseAssertion: Hypertrophic Cardiomyopathy
FamilyInfo: N/A
CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)
HPOsFreeText: N/A
CaseNotHPOs: N/A
NotHPOsFreeText: N/A
CaseAddInfo: N/A
CasePreviousTesting: See Table 1
CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.
Variant: NM_000257.3:c.1208G>A (p.Arg403Gln)
ClinVar: 14087 https://www.ncbi.nlm.nih.gov/clinvar/variation/14087/
gnomAD: Not in gnomAD
CaseMYH7-24: Australia
DiseaseAssertion: Hypertrophic Cardiomyopathy
FamilyInfo: N/A
CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)
HPOsFreeText: N/A
CaseNotHPOs: N/A
NotHPOsFreeText: N/A
CaseAddInfo: N/A
CasePreviousTesting: See Table 1
CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.
Variant: NM_000257.3:c.2221G>T (p.Gly741Trp)
ClinVar: 177665 https://www.ncbi.nlm.nih.gov/clinvar/variation/177665/
gnomAD: Not in gnomAD
CaseMYH7-6: Australia
DiseaseAssertion: Hypertrophic Cardiomyopathy
FamilyInfo: N/A
CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)
HPOsFreeText: N/A
CaseNotHPOs: N/A
NotHPOsFreeText: N/A
CaseAddInfo: 2 other probands have this genotype
CasePreviousTesting: See Table 1
CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.
Variant: NM_000257.3:c.4135G>A (p.Ala1379Thr)
ClinVar: 42993 https://www.ncbi.nlm.nih.gov/clinvar/variation/42993/
gnomAD: Latino 2.822e-5, Overall 3.535e-6 https://gnomad.broadinstitute.org/variant/14-23887453-C-T
CaseMYH7-37: Australia
DiseaseAssertion: Hypertrophic Cardiomyopathy
FamilyInfo: N/A
CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)
HPOsFreeText: N/A
CaseNotHPOs: N/A
NotHPOsFreeText: N/A
CaseAddInfo: N/A
CasePreviousTesting: See Table 1
CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.
Variant: NM_000257.3:c.1207C>T (p.Arg403Trp)
ClinVar: 14102 https://www.ncbi.nlm.nih.gov/clinvar/variation/14102/
gnomAD: Not in gnomAD
CaseMYH7-13: Australia
DiseaseAssertion: Hypertrophic Cardiomyopathy
FamilyInfo: N/A
CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)
HPOsFreeText: N/A
CaseNotHPOs: N/A
NotHPOsFreeText: N/A
CaseAddInfo: N/A
CasePreviousTesting: See Table 1
CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.
Variant: NM_000257.3:c.3064A>G (p.Lys1022Glu)
CAID: CA389045738 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000257.3%3Ac.3064A%3EG
gnomAD: Not in gnomAD
DiseaseAssertion: Hypertrophic Cardiomyopathy
VariantPreviousTesting: ACTC1, ACTN2, CSRP3, LAMP2, MYBPC3, MYH7, NEXN, PLN, TNNC1, TNNI3, TNNT2, TPM1, CAV3, GLA, MYL2, MYL3, MYOZ2, PRKAG2, and TTR were all tested via NGS.
VariantGenotypingMethod: Next-generation sequencing panels were used to sequence and read the genetic information of the 760 HCM probands for variants within exons and in +/- 10 nucleotides within the flanking introns of the genes provided above. These variants were then interpreted and filtered for pathogenicity.
VariantAddInfo: Seen in one HCM proband
Variant: NM_000257.4(MYH7):c.2332G>A (p.Asp778Asn)
ClinVarID: 181369 https://www.ncbi.nlm.nih.gov/clinvar/variation/181369/
gnomAD: Not in gnomAD
DiseaseAssertion: Hypertrophic Cardiomyopathy
VariantPreviousTesting: ACTC1, ACTN2, CSRP3, LAMP2, MYBPC3, MYH7, NEXN, PLN, TNNC1, TNNI3, TNNT2, TPM1, CAV3, GLA, MYL2, MYL3, MYOZ2, PRKAG2, and TTR were all tested via NGS.
VariantGenotypingMethod: Next-generation sequencing panels were used to sequence and read the genetic information of the 760 HCM probands for variants within exons and in +/- 10 nucleotides within the flanking introns of the genes provided above. These variants were then interpreted and filtered for pathogenicity.
VariantAddInfo: Seen in one proband
Variant: NM_000257.4(MYH7):c.1231G>A (p.Val411Ile)
ClinVarID: 181339 https://www.ncbi.nlm.nih.gov/clinvar/variation/181339/
gnomAD: 0.00005643, http://gnomad.broadinstitute.org/variant/14-23898464-C-T
DiseaseAssertion: None
VariantPreviousTesting: Some combination of ACTC1, ACTN2, CSRP3, LAMP2, MYBPC3, MYH7, NEXN, PLN, TNNC1, TNNI3, TNNT2, TPM1, ABCC9, CTF1, DES, EMD, LDB3, LMNA, MYH6, RBM20, SGCD, TAZ, TCAP, TTN, VCL, CAV3, GLA, MYL2, MYL3, MYOZ2, PRKAG2, TTR, DSC2, DSG2, DSP, JUP, PKP2, RYR2, TMEM43, CASQ2 and RYR2 were tested via NGS.
VariantGenotypingMethod: Next-generation sequencing panels were used to sequence and read the genetic information of probands for variants within exons and in +/- 10 nucleotides within the flanking introns of the genes provided above. These variants were then interpreted and filtered for pathogenicity.
Variant: NM_000257.4(MYH7):c.2360G>A (p.Arg787His)
ClinVar: 42900 https://www.ncbi.nlm.nih.gov/clinvar/variation/42900/
gnomAD: 0.001339, http://gnomad.broadinstitute.org/variant/14-23894554-C-T
DiseaseAssertion: Cardiomyopathy
VariantPreviousTesting: ACTC1, ACTN2, CSRP3, LAMP2, MYBPC3, MYH7, NEXN, PLN, TNNC1, TNNI3, TNNT2, TPM1, ABCC9, CTF1, DES, EMD, LDB3, LMNA, MYH6, RBM20, SGCD, TAZ, TCAP, TTN, VCL, CAV3, GLA, MYL2, MYL3, MYOZ2, PRKAG2, TTR, DSC2, DSG2, DSP, JUP, PKP2, RYR2, TMEM43, CASQ2 and RYR2 were all tested in the PanCM panel.
VariantGenotypingMethod: Next-generation sequencing panels were used to sequence and read the genetic information of the 305 PanCM probands for variants within exons and in +/- 10 nucleotides within the flanking introns of the genes provided above. These variants were then interpreted and filtered for pathogenicity.
VariantAddInfo: Seen in one PanCM proband
Variant: NM_000257.4(MYH7):c.2770G>A (p.Glu924Lys)
ClinVar: 14092 https://www.ncbi.nlm.nih.gov/clinvar/variation/14092/
gnomAD: Not in gnomAD
DiseaseAssertion: Hypertrophic Cardiomyopathy
VariantPreviousTesting: ACTC1, ACTN2, CSRP3, LAMP2, MYBPC3, MYH7, NEXN, PLN, TNNC1, TNNI3, TNNT2, TPM1, CAV3, GLA, MYL2, MYL3, MYOZ2, PRKAG2, and TTR were all tested via NGS.
VariantGenotypingMethod: Next-generation sequencing panels were used to sequence and read the genetic information of the 760 HCM probands for variants within exons and in +/- 10 nucleotides within the flanking introns of the genes provided above. These variants were then interpreted and filtered for pathogenicity.
VariantAddInfo: Seen in two HCM probands
Variant: NM_000257.4(MYH7):c.2156G>A (p.Arg719Gln)
ClinVarID: 14107 https://www.ncbi.nlm.nih.gov/clinvar/variation/14107/
gnomAD: Not in gnomAD
DiseaseAssertion: Hypertrophic Cardiomyopathy
VariantPreviousTesting: ACTC1, ACTN2, CSRP3, LAMP2, MYBPC3, MYH7, NEXN, PLN, TNNC1, TNNI3, TNNT2, TPM1, CAV3, GLA, MYL2, MYL3, MYOZ2, PRKAG2, and TTR were all tested via NGS.
VariantGenotypingMethod: Next-generation sequencing panels were used to sequence and read the genetic information of the 760 HCM probands for variants within exons and in +/- 10 nucleotides within the flanking introns of the genes provided above. These variants were then interpreted and filtered for pathogenicity.
VariantAddInfo: Seen in two probands
Variant: NM_000257.4(MYH7):c.1207C>T (p.Arg403Trp)
ClinVarID: 14102 https://www.ncbi.nlm.nih.gov/clinvar/variation/14102/
gnomAD: Not in gnomAD
DiseaseAssertion: Hypertrophic Cardiomyopathy
VariantPreviousTesting: ACTC1, ACTN2, CSRP3, LAMP2, MYBPC3, MYH7, NEXN, PLN, TNNC1, TNNI3, TNNT2, TPM1, CAV3, GLA, MYL2, MYL3, MYOZ2, PRKAG2, and TTR were all tested via NGS.
VariantGenotypingMethod: Next-generation sequencing panels were used to sequence and read the genetic information of the 760 HCM probands for variants within exons and in +/- 10 nucleotides within the flanking introns of the genes provided above. These variants were then interpreted and filtered for pathogenicity.
VariantAddInfo: Seen in one HCM probands
Variant: NM_000257.4(MYH7):c.746G>A (p.Arg249Gln)
ClinVar: 14088 https://www.ncbi.nlm.nih.gov/clinvar/variation/14088/
gnomAD: Not in gnomAD
CaseMYH7-8: N/A
DiseaseAssertion: Hypertrophic Cardiomyopathy
FamilyInfo: N/A
CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)
HPOsFreeText: N/A
CaseNotHPOs: N/A
NotHPOsFreeText: N/A
CaseAddInfo: N/A
CaseGenotypingMethod: Testing for all 8 sarcomeric genes, plus GLA, LAMP2, and PRKAG2 was initiated in all probands. After the direct sequencing, the variants were filtered for pathogenicity and classified.
Variant: NM_000257.3:c.427C>T (p.Arg143Trp)
ClinVar: 164401 https://www.ncbi.nlm.nih.gov/clinvar/variation/164401/
gnomAD: East Asian 1.087e-4, Overall 2.784e-5 https://gnomad.broadinstitute.org/variant/14-23901923-G-A
CaseMYH7-16: N/A
DiseaseAssertion: Hypertrophic Cardiomyopathy
FamilyInfo: N/A
CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)
HPOsFreeText: N/A
CaseNotHPOs: N/A
NotHPOsFreeText: N/A
CaseAddInfo: N/A
CaseGenotypingMethod: Testing for all 8 sarcomeric genes, plus GLA, LAMP2, and PRKAG2 was initiated in all probands. After the direct sequencing, the variants were filtered for pathogenicity and classified.
Variant: NM_000257.3:c.2681A>G (p.Glu894Gly)
ClinVar: 42922 https://www.ncbi.nlm.nih.gov/clinvar/variation/42922/
gnomAD: Not in gnomAD
CaseMYH7-22: N/A
DiseaseAssertion: Hypertrophic Cardiomyopathy
FamilyInfo: N/A
CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)
HPOsFreeText: N/A
CaseNotHPOs: N/A
NotHPOsFreeText: N/A
CaseAddInfo: N/A
CaseGenotypingMethod: Testing for all 8 sarcomeric genes, plus GLA, LAMP2, and PRKAG2 was initiated in all probands. After the direct sequencing, the variants were filtered for pathogenicity and classified.
Variant: NM_000257.3:c.2788G>A (p.Glu930Lys)
ClinVar: 42933 https://www.ncbi.nlm.nih.gov/clinvar/variation/42933/
gnomAD: Not in gnomAD
CaseMYH7-26: N/A
DiseaseAssertion: Hypertrophic Cardiomyopathy
FamilyInfo: N/A
CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)
HPOsFreeText: N/A
CaseNotHPOs: N/A
NotHPOsFreeText: N/A
CaseAddInfo: N/A
CaseGenotypingMethod: Testing for all 8 sarcomeric genes, plus GLA, LAMP2, and PRKAG2 was initiated in all probands. After the direct sequencing, the variants were filtered for pathogenicity and classified.
Variant: NM_000257.3:c.2609G>A (p.Arg870His)
ClinVar: 14120 https://www.ncbi.nlm.nih.gov/clinvar/variation/14120/
gnomAD: European (Non-Finnish) 1.549e-5, Overall 7.072e-6 https://gnomad.broadinstitute.org/variant/14-23894048-C-T
CaseMYH7-1: N/A
DiseaseAssertion: Hypertrophic Cardiomyopathy
FamilyInfo: N/A
CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)
HPOsFreeText: N/A
CaseNotHPOs: N/A
NotHPOsFreeText: N/A
CaseAddInfo: N/A
CaseGenotypingMethod: Testing for all 8 sarcomeric genes, plus GLA, LAMP2, and PRKAG2 was initiated in all probands. After the direct sequencing, the variants were filtered for pathogenicity and classified.
Variant: NM_000257.3:c.1987C>T (p.Arg663Cys)
ClinVar: 42874 https://www.ncbi.nlm.nih.gov/clinvar/variation/42874/
gnomAD: Not in gnomAD
CaseMYH7-13: N/A
DiseaseAssertion: Hypertrophic Cardiomyopathy
FamilyInfo: N/A
CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)
HPOsFreeText: N/A
CaseNotHPOs: N/A
NotHPOsFreeText: N/A
CaseAddInfo: N/A
CaseGenotypingMethod: Testing for all 8 sarcomeric genes, plus GLA, LAMP2, and PRKAG2 was initiated in all probands. After the direct sequencing, the variants were filtered for pathogenicity and classified.
Variant: NM_000257.3:c.1208G>A (p.Arg403Gln)
ClinVar: 14087 https://www.ncbi.nlm.nih.gov/clinvar/variation/14087/
gnomAD: Not in gnomAD
CaseCM1839: Female, 12 years diagnosis, Japan, Asian
CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)
HPOsFreeText: N/A
CaseNotHPOs: HP:0001939 (Abnormality of metabolism/homeostasis)
NotHPOsFreeText: Neuromuscular disease, Malformation syndromes
CaseAddInfo: Positive family history of cardiomyopathy or sudden death, Proband found in Supplementary Table 2
CasePreviousTesting: 8 patients with HCM and one with RCM were analyzed by NGS for the eight sarcomere-encoding genes and MYP.
CaseGenotypingMethod: Probands were subject to PCR amplification and direct sequencing of 64 cardiomyopathy-associated genes, including the eight sarcomere-encoding genes. The variants were then filtered for rarity and tested for pathogenicity.
Variant: NM_000257.3:c.2221G>T (p.Gly741Trp)
ClinVar: 177665 https://www.ncbi.nlm.nih.gov/clinvar/variation/177665/
gnomAD: Not in gnomAD
MultipleGeneVariants:
(1) BAG3 Variant Variant: NM_004281.3:c.1015A>G (p.Ile339Val)
ClinVar: 228453 https://www.ncbi.nlm.nih.gov/clinvar/variation/228453/
gnomAD: East Asian 5.437e-5, Overall 3.976e-6 https://gnomad.broadinstitute.org/variant/10-121436081-A-G
CaseCM1871: Male, 0 years diagnosis, Japan, Asian
CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)
HPOsFreeText: N/A
CaseNotHPOs: HP:0001939 (Abnormality of metabolism/homeostasis)
NotHPOsFreeText: Neuromuscular disease, Malformation syndromes
CaseAddInfo: No family history of cardiomyopathy or sudden death, Proband found in Supplementary Table 2, Mother shows negative for this variant with no symptoms
CasePreviousTesting: 8 patients with HCM and one with RCM were analyzed by NGS for the eight sarcomere-encoding genes and MYP.
CaseGenotypingMethod: Probands were subject to PCR amplification and direct sequencing of 64 cardiomyopathy-associated genes, including the eight sarcomere-encoding genes. The variants were then filtered for rarity and tested for pathogenicity.
Variant: NM_000257.3:c.2608C>T (p.Arg870Cys)
ClinVar: 161326 https://www.ncbi.nlm.nih.gov/clinvar/variation/161326/
gnomAD: Ashkenazi Jewish 9.923e-5, Overall 2.386e-5 https://gnomad.broadinstitute.org/variant/14-23894049-G-A
CaseCM1844: Male, 6 years diagnosis, Japan, Asian
CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)
HPOsFreeText: N/A
CaseNotHPOs: HP:0001939 (Abnormality of metabolism/homeostasis)
NotHPOsFreeText: Neuromuscular disease, Malformation syndromes
CaseAddInfo: No family history of cardiomyopathy or sudden death, Proband found in Supplementary Table 2, Mother and father are both negative for this variant
CasePreviousTesting: 8 patients with HCM and one with RCM were analyzed by NGS for the eight sarcomere-encoding genes and MYP.
CaseGenotypingMethod: Probands were subject to PCR amplification and direct sequencing of 64 cardiomyopathy-associated genes, including the eight sarcomere-encoding genes. The variants were then filtered for rarity and tested for pathogenicity.
Variant: NM_000257.3:c.1357C>T (p.Arg453Cys)
ClinVar: 14089 https://www.ncbi.nlm.nih.gov/clinvar/variation/14089/
gnomAD: Not in gnomAD
21
CaseVI: Brazil, Caucasian
DiseaseAssertion: Hypertrophic cardiomyopathy
FamilyInfo: Family history of HCM
CasePresentingHPOs: HP:0001712, HP:0001639 (Left ventricular hypertrophy, Hypertrophic cardiomyopathy)
HPOsFreeText: N/A
CaseNotHPOs: N/A
NotHPOsFreeText: N/A
CaseAddInfo: N/A
CasePreviousTesting: Only MYH7, MYBPC3, and TNNT2 were tested.
CaseGenotypingMethod: DNA was extracted from peripheral blood and the above genes were subject to PCR amplification and directly sequenced. The resulting sequences were compared with the reference and filtered for pathogenicity.
Variant: NM_000257.3:c.2389G>A (p.Ala797Thr)
ClinVar: 42901 https://www.ncbi.nlm.nih.gov/clinvar/variation/42901/
gnomAD: African 1.230e-4, Overall 2.386e-5 https://gnomad.broadinstitute.org/variant/14-23894525-C-T
HCM1.1
CaseHCM1.1: Indian
DiseaseAssertion: Hypertrophic Cardiomyopathy
FamilyInfo: N/A
CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)
HPOsFreeText: N/A
CaseNotHPOs: HP:0000819 (Diabetes mellitus)
NotHPOsFreeText: N/A
CaseAddInfo: N/A
CasePreviousTesting: See Table 1
CaseGenotypingMethod: DNA was extracted from the probands' blood, followed by sequencing of the coding regions and exon/intron boundaries of 15 genes associated with HCM. From there, they were amplified by PCR ampliication and variants were filtered by pathogenicity. Every unclassified variant was confirmed by Sanger sequencing afterwards.
Variant: NM_000257.3:c.611G>A (p.Arg204His)
ClinVar: 43095 https://www.ncbi.nlm.nih.gov/clinvar/variation/43095/
gnomAD: East Asian 5.012e-5, Overall 1.767e-5 https://gnomad.broadinstitute.org/variant/14-23900998-C-T
HCM34.1
CaseHCM34.1: Mixed ancestry
DiseaseAssertion: Hypertrophic Cardiomyopathy
FamilyInfo: N/A
CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)
HPOsFreeText: N/A
CaseNotHPOs: HP:0000819 (Diabetes mellitus)
NotHPOsFreeText: N/A
CaseAddInfo: N/A
CasePreviousTesting: See Table 1
CaseGenotypingMethod: DNA was extracted from the probands' blood, followed by sequencing of the coding regions and exon/intron boundaries of 15 genes associated with HCM. From there, they were amplified by PCR ampliication and variants were filtered by pathogenicity. Every unclassified variant was confirmed by Sanger sequencing afterwards.
Variant: NM_000257.3:c.1357C>T (p.Arg453Cys)
ClinVar: 14089 https://www.ncbi.nlm.nih.gov/clinvar/variation/14089/
gnomAD: Not in gnomAD
HCM14.1
CaseHCM14.1: Mixed ancestry
DiseaseAssertion: Hypertrophic Cardiomyopathy
FamilyInfo: N/A
CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)
HPOsFreeText: N/A
CaseNotHPOs: HP:0000819 (Diabetes mellitus)
NotHPOsFreeText: N/A
CaseAddInfo: N/A
CasePreviousTesting: See Table 1
CaseGenotypingMethod: DNA was extracted from the probands' blood, followed by sequencing of the coding regions and exon/intron boundaries of 15 genes associated with HCM. From there, they were amplified by PCR ampliication and variants were filtered by pathogenicity. Every unclassified variant was confirmed by Sanger sequencing afterwards.
Variant: NM_000257.3:c.2167C>T (p.Arg723Cys)
ClinVar: 14095 https://www.ncbi.nlm.nih.gov/clinvar/variation/14095/
gnomAD: South Asian 3.266e-5, Overall 1.194e-5 https://gnomad.broadinstitute.org/variant/14-23895023-G-A
CasePT-38: United States
CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)
HPOsFreeText: N/A
CaseNotHPOs: HP:0001650, HP:0001658 (Aortic valve stenosis, Myocardial infarction)
NotHPOsFreeText: N/A
CaseAddInfo: Two other siblings have the same genotype
CaseGenotypingMethod: DNA was collected from the participants using blood samples. 18 genes suspected on contributing to HCM were targeted and sequenced. The variants were then located and filtered for pathogenicity.
Variant: NM_000257.3:c.727C>T (p.Arg243Cys)
ClinVar: 43101 https://www.ncbi.nlm.nih.gov/clinvar/variation/43101/
gnomAD: European (Non-Finnish) 6.482e-5, Overall 3.184e-5 https://gnomad.broadinstitute.org/variant/14-23900799-G-A
CasePT-62: United States
CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)
HPOsFreeText: N/A
CaseNotHPOs: HP:0001650, HP:0001658 (Aortic valve stenosis, Myocardial infarction)
NotHPOsFreeText: N/A
CaseAddInfo:
CaseGenotypingMethod: DNA was collected from the participants using blood samples. 18 genes suspected on contributing to HCM were targeted and sequenced. The variants were then located and filtered for pathogenicity.
Variant: NM_000257.3:c.1370T>C (p.Ile457Thr)
ClinVar: 42840 https://www.ncbi.nlm.nih.gov/clinvar/variation/42840/
gnomAD: European (Non-Finnish) 8.790e-6, Overall 3.976e-6 https://gnomad.broadinstitute.org/variant/14-23898201-A-G
Family B, II:1
CaseBII-1: Male, 23 years diagnosis, China, Asian
DiseaseAssertion: Hypertrophic Cardiomyopathy
FamilyInfo: No family history, pedigree provided
CasePresentingHPOs: HP:0001639, HP:0100749 (Hypertrophic cardiomyopathy, Chest pain)
HPOsFreeText: Interventricular septal thickness at 15.6 mm, Left ventricular posterior wall thickness at 12.1 mm
CaseNotHPOs: N/A
NotHPOsFreeText: N/A
CaseAddInfo: Parents tested negative for variant, therefore it is asserted as de novo
CasePreviousTesting: See list of sequenced genes
CaseGenotypingMethod: Genomic DNA was isolated from whole blood of all patients and controls. Whole coding exons and exon-intron boundaries of the 19 HCM-related genes listed above were amplified and sequenced on Ion Torrent PGM. These variants were then filtered for pathogenicity and compared to the controls. Any mutations found were confirmed by conventional dideoxy sequencing and Sanger sequencing.
Variant: NM_000257.3:c.2572C>T (p.Arg858Cys)
ClinVar: 164324 https://www.ncbi.nlm.nih.gov/clinvar/variation/164324/
gnomAD: Not in gnomAD
A14
CaseA14: Female, 44 years report, China, Asian
DiseaseAssertion: Hypertrophic Cardiomyopathy
FamilyInfo: No family history
CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)
HPOsFreeText: Interventricular septal thickness at 17.6 mm, Left ventricular posterior wall thickness at 8.8 mm, Left ventricular end-diastolic diameter at 42.7 mm, Left ventricular septal thickness at 36.6 mm, Left ventricular ejection fraction at 68%
CaseNotHPOs: N/A
NotHPOsFreeText: N/A
CaseAddInfo: N/A
CasePreviousTesting: See list of sequenced genes
CaseGenotypingMethod: Genomic DNA was isolated from whole blood of all patients and controls. Whole coding exons and exon-intron boundaries of the 19 HCM-related genes listed above were amplified and sequenced on Ion Torrent PGM. These variants were then filtered for pathogenicity and compared to the controls. Any mutations found were confirmed by conventional dideoxy sequencing and Sanger sequencing.
Variant: NM_000257.3:c.161G>A (p.Arg54Gln)
ClinVar: 42856 https://www.ncbi.nlm.nih.gov/clinvar/variation/42856/
gnomAD: East Asian 2.506e-4, Overall 2.475e-5 https://gnomad.broadinstitute.org/variant/14-23902781-C-T
CaseST4-91: Sweden
DiseaseAssertion: Idiopathic Dilated Cardiomyopathy
FamilyInfo: N/A
CasePresentingHPOs: HP:0001644 (Dilated cardiomyopathy)
HPOsFreeText: N/A
CaseNotHPOs: HP:0002140, HP:0000822, HP:0001654, HP:0030955, HP:0000819, HP:0002666, HP:0000845, HP:0000820 (Ischemic stroke, Hypertension, Valvular heart disease, Alcoholism, Diabetes mellitus, Pheochromocytoma, Acromegaly, Thyroid disease)
NotHPOsFreeText: Patients were excluded for significant systemic infection, systemic diseases, previous cancer treatment including irradiation, and tachycardia-induced cardiomyopathy or other primary cardiomyopathy.
CaseAddInfo: N/A
CasePreviousTesting: See Supplemental Table 1
CaseGenotypingMethod: Genomic DNA was extracted from the patients. 41 exons of previously-reported genes that were reported in DCM patients were amplified and directly sequenced. Afterwards, the variants were aligned and sorted for pathogenicity.
Variant: NM_000257.3:c.1113G>C (p.Glu371Asp)
CAID: CA389051328 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000257.3%3Ac.1113G%3EC
gnomAD: Not in gnomAD
Contractile heterogeneity of individual cardiomyocytes from HCM-patients compared to donor cardiomyocytes. Single cardiomyocytes were isolated from frozen heart tissue of HCM-patients (red) with the mutation R723G (left) or A200V (right), respectively, and from donor individuals (blue) as controls. Cardiomyocytes were permeabilized, and after adjustment of phosphorylation levels [57, 61, 80, 114, 119], they were subjected to different calcium concentrations and the respective force generation was measured. Depicted are the forces of individual left ventricular cardiomyocytes at different calcium concentrations (force-pCa-relations), normalized to maximum force. Each symbol and curve represents a different individual cell. The boxes at physiological calcium concentration highlight the much larger variance in force generation among individual cardiomyocytes from the patients compared to controls. Figure reprinted from [82] and modified, with permission from Frontiers
Variant 1: NM_000257.4(MYH7):c.2167C>G (p.Arg723Gly)
ClinVar: 42885, https://www.ncbi.nlm.nih.gov/clinvar/variation/42885/
gnomAD: n/a
Variant 2: NM_000257.4:c.599C>T (p.Ala200Val)
CAID: CA389052449, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA389052449
gnomAD: n/a
CaseIP-2: Male, Taiwan, Birth diagnosis
HPOsFreeText: 4MU enzyme activity at 0.43, MS/MS ennzyme activity at 0.13
GenotypingMethod: GAA Gene Sequencing and PCR Amplification
Variant in literature as c.1396C>T, however the reference has G there. Corrected for poossible typo.
Variant1: NM_000152.4:c.1396G>T (p.Val466Phe)
CAID: CA401366509 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.1396G%3ET
gnomAD: Not in gnomAD
Variant2: NM_000152.4:c.1935C>A (p.Asp645Glu)
ClinVar: 4029 https://www.ncbi.nlm.nih.gov/clinvar/variation/4029/
gnomAD: East Asian 1.729e-3, Overall 1.240e-4 http://gnomad.broadinstitute.org/variant/17-78086721-C-A
CaseAddInfo: Infantile Onset Pompe Disease
CaseLP2-2: Female, Taiwan, Birth diagnosis
HPOsFreeText: GAA (MS/MS) enzyme activity at 0.08 umol/hr/L, Serum CK at 109 U/L
GenotypingMethod: GAA Gene Sequencing and PCR Amplification
Variant1: NM_000152.4:c.424_440del17 (p.Ser142Leufs*29)
CAID: CA658795228 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.424_440del17
gnomAD: Not in gnomAD
Variant2: NM_000152.4:c.1958C>A (p.Thr653Asn)
CAID: CA8815557 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.1958C%3EA
gnomAD: East Asian 2.548e-4, Overall 1.825e-5 http://gnomad.broadinstitute.org/variant/17-78086744-C-A
CaseAddInfo: Late Onset Pompe Disease
CaseIP2-11: Male, Taiwan, Birth diagnosis
HPOsFreeText: GAA (MS/MS) enzyme activity at 0.15 umol/hr/L, Serum CK at 662 U/L
GenotypingMethod: GAA Gene Sequencing and PCR Amplification
Variant1: NM_000152.4:c.1935C>A (p.Asp645Glu)
ClinVar: 4029 https://www.ncbi.nlm.nih.gov/clinvar/variation/4029/
gnomAD: East Asian 1.729e-3, Overall 1.240e-4 http://gnomad.broadinstitute.org/variant/17-78086721-C-A
Variant2: NM_000152.4:c.1726G>A (p.Gly576Ser)
ClinVar: 92467 https://www.ncbi.nlm.nih.gov/clinvar/variation/92467/
gnomAD: East Asian 0.1427, Overall 0.01700 http://gnomad.broadinstitute.org/variant/17-78085871-G-A
Variant3: NM_000152.4:c.2303C>T (p.Pro768Leu)
CAID: CA401324900 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.2303C%3ET
gnomAD: Not in gnomAD
CaseAddInfo: Infantile Onset Pompe Disease, Nomenclature indicates that Variant 1 and 3 are in trans and that 2 is in cis with one of them
CaseOPOPD-47: Male, Taiwan, Birth diagnosis
HPOsFreeText: GAA (MS/MS) enzyme activity at 0.83 umol/hr/L
GenotypingMethod: GAA Gene Sequencing and PCR Amplification
Variant1: NM_000152.4:c.1461C>G (p.Phe487Leu)
CAID: CA401366857 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.1461C%3EG
gnomAD: Not in gnomAD
Variant2: NM_000152.4:c.1726G>A (p.Gly576Ser)
ClinVar: 92467 https://www.ncbi.nlm.nih.gov/clinvar/variation/92467/
gnomAD: East Asian 0.1427, Overall 0.01700 http://gnomad.broadinstitute.org/variant/17-78085871-G-A
CaseAddInfo: One Pompe Mutation allele and One Pseudodeficency Mutation allele
CaseOPOPD-52: Female, Taiwan, Birth diagnosis
HPOsFreeText: GAA (MS/MS) enzyme activity at 1.13 umol/hr/L
GenotypingMethod: GAA Gene Sequencing and PCR Amplification
Variant1: NM_000152.4:c.1726G>A (p.Gly576Ser)
ClinVar: 92467 https://www.ncbi.nlm.nih.gov/clinvar/variation/92467/
gnomAD: East Asian 0.1427, Overall 0.01700 http://gnomad.broadinstitute.org/variant/17-78085871-G-A
Variant2: NM_000152.4:c.1850T>G (p.Val617Gly)
CAID: CA401369628 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.1850T%3EG
gnomAD: Not in gnomAD
CaseAddInfo: One Pompe Mutation allele and One Pseudodeficency Mutation allele
CaseOPM-2: Male, Taiwan, Birth diagnosis
HPOsFreeText: GAA (MS/MS) enzyme activity at 1.34 umol/hr/L
GenotypingMethod: GAA Gene Sequencing and PCR Amplification
Variant1: NM_000152.4:c.693-5C>T
CAID: CA8814990 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.693-5C%3ET
gnomAD: East Asian 3.516e-4, Overall 3.900e-5 http://gnomad.broadinstitute.org/variant/17-78081351-C-T
Variant2: NM_000152.4:c.1726G>A (p.Gly576Ser)
ClinVar: 92467 https://www.ncbi.nlm.nih.gov/clinvar/variation/92467/
gnomAD: East Asian 0.1427, Overall 0.01700 http://gnomad.broadinstitute.org/variant/17-78085871-G-A
CaseAddInfo: One Pompe Mutation, Nomenclature indicates Variants 1 and 2 are in cis and the other allele is Wildtype
28
Case28: Female, 6 yr onset, 7 yr diagnosis, 9.9 yr report
HPOsFreeText: Wheelchair partially used beginning at 9 yr, Respiratory support used at night beginning at 8 yr, FVC z-score sitting -6.36 (30% pred), FVC z-score supine -6.88 (25% pred), 82% MRC Scale, 979 CK U/l, 0.3 GAA activity (nmol/h/mg)^h from cultured fibroblasts
2
Case2: Female, Birth diagnosis, 0.8 yr onset
HPOsFreeText: 258 CK U/l, Deficient GAA activity (nmol/h/mg)^h from cultured fibroblasts
NotHPOsFreeText: No wheelchair used, no respiratory support
26
Case26: Female, 4 yr onset, 4 yr diagnosis, 8.1 yr report
HPOsFreeText: FVC z-score sitting 0.01 (100% pred), FVC z-score supine -0.63 (92% pred), 98% MRC Scale, 572 CK U/l, 2.3 GAA activity (nmol/h/mg)^h from cultured fibroblasts
NotHPOsFreeText: No wheelchair used, No respiratory support
22
Case22: Male, 0.5 yr onset, 1 yr diagnosis, 1.3 yr report
HPOsFreeText: Wheelchair used at 4 yr, Died of respiratory failure at 10 yr, FVC z-score sitting -4.77 (45% pred) at 9 yr, 586 CK U/l, Deficient GAA activity (nmol/h/mg)^h from cultured fibroblasts
PD22
Patient22: Female, Southern China
CasePresentingHPOs:
HPOsFreeText: IOPD
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo:
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: NM_000152.3:c.1241del
CAID: CA913184736, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA913184736
gnomAD: n/a
Variant2: NM_000152.4(GAA):c.2662G>T (p.Glu888Ter)
ClinVar: 578595, https://www.ncbi.nlm.nih.gov/clinvar/variation/578595/
gnomAD: 1.65e-05, http://exac.broadinstitute.org/variant/17-78092467-G-T
PD12
Patient12: Male, Southern China
CasePresentingHPOs:
HPOsFreeText: IOPD
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo:
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: NM_000152.3:c.2585del
CAID: CA913184734, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA913184734
gnomAD: n/a
Variant2: NM_000152.4(GAA):c.2815_2816delGT (p.Val939Leufs)
ClinVar: 371481, https://www.ncbi.nlm.nih.gov/clinvar/variation/371481/
gnomAD: 1.653e-05, http://exac.broadinstitute.org/variant/17-78093082-CTG-C
PD17
Patient17: Female, Southern China
CasePresentingHPOs:
HPOsFreeText: IOPD
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo:
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: NM_000152.4(GAA):c.1935C>A (p.Asp645Glu)
ClinVar: 4029, https://www.ncbi.nlm.nih.gov/clinvar/variation/4029/
gnomAD: 0.0001721, http://exac.broadinstitute.org/variant/17-78086721-C-A
Variant2: NM_000152.4(GAA):c.2815_2816delGT (p.Val939Leufs)
ClinVar: 371481, https://www.ncbi.nlm.nih.gov/clinvar/variation/371481/
gnomAD: 1.653e-05, http://exac.broadinstitute.org/variant/17-78093082-CTG-C
PD03
Patient3: Male, northern China
CasePresentingHPOs:
HPOsFreeText: IOPD
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo:
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: NM_000152.3:c.2024A>G
CAID: CA401370120, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA401370120
gnomAD: n/a
Variant2: NM_000152.4(GAA):c.2132C>G (p.Thr711Arg)
ClinVar: 381006, https://www.ncbi.nlm.nih.gov/clinvar/variation/381006/
gnomAD: 0.0001488, http://exac.broadinstitute.org/variant/17-78087108-C-G
PD19
Patient19: Male, Southern China
CasePresentingHPOs:
HPOsFreeText: IOPD
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo:
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: NM_000152.4(GAA):c.1935C>A (p.Asp645Glu)
ClinVar: 4029, https://www.ncbi.nlm.nih.gov/clinvar/variation/4029/
gnomAD: 0.0001721, http://exac.broadinstitute.org/variant/17-78086721-C-A
Variant2: NM_000152.4(GAA):c.2815_2816delGT (p.Val939Leufs)
ClinVar: 371481, https://www.ncbi.nlm.nih.gov/clinvar/variation/371481/
gnomAD: 1.653e-05, http://exac.broadinstitute.org/variant/17-78093082-CTG-C
PD11
Patient11: Male, Southern China
CasePresentingHPOs:
HPOsFreeText: IOPD, survived beyond 2yo, left ventricular mass index and left ventricular posterior wall thickness decreased during ERT. Able to raise head, sit without support, stand, walk alone
CaseNotHPOs: no significant respiratory problems during ERT
NotHPOsFreeText:
CaseAddInfo: homozygous, only patient to receive ERT treatment (rhGAA) every 2wks beginning at 5mo of age. ERT lasted for 90wks.
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant: NM_000152.4(GAA):c.1935C>A (p.Asp645Glu)
ClinVar: 4029, https://www.ncbi.nlm.nih.gov/clinvar/variation/4029/
gnomAD: 0.0001721, http://exac.broadinstitute.org/variant/17-78086721-C-A
11
Case#: Patient 11, Gender N/A, Onset at 3-4 months. Death when 1-2 years old, Southeast Asian
DiseaseAssertion: Parents are
FamilyInfo: Proband parents are consanguineous family
CasePresentingHPOs: HP:0001252, HP:0002240 Muscular hypotonia, Hepatomegaly
CaseHPOFreeText: BVH, SDD
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CasePreviousTesting: GAA enzyme activity is not available.
PCR of all exons was performed and subsequently subjected to capillary Sanger sequencing in both directions
Variant: NM_000152.5(GAA):c.1895T>G (p.Leu632Arg)
ClinVar: 637961
CAID: CA401369835
gnomAD: N/A
ParentalGenotype: Both parents were carriers of the variant c.1895T>G (p.Leu632Arg)
PreviouslyPublished:
Modeling CNS Involvement in Pompe Disease Using Neural Stem Cells Generated from Patient-Derived Induced Pluripotent Stem Cells
PMID: PMC7822217
Gene: GAA
Disease: Pompe Disease
Inheritance: Autosomal Recessive
#2
Case#: Subject number 2, female, 7 years (report)
DiseaseAssertion: Pompe disease
FamilyInfo: Family member with PD
CasePresentingHPOs:
CaseHPOFreeText: Asymptomatic
CaseNotHPOs: HP:0002153 (hyperkalemia), HP:0001324 (muscle weakness), HP:0003546 (Exercise intolerance), HP:0001252 (Hypotonia), HP:0003326 (Myalgia), HP:0002015 (dysphagia), HP:0002098 (respiratory distress), HP:0002094 (dyspnoea), HP:0001638 (cardiomyopathy)
CaseNotHPOFreeText: no biopsy
CasePreviousTesting: "Enzymatic activity was detected by fluorometric techniques" "The GAA sequence was performed in all patients whose enzyme activity measured in DBS and lymphocytes was decreased."
glucosidase activity: GAA activity was 0.12 mol/Lh in dried blood spots (normal range >0.75).
Variant 1: NM_000152.5(GAA):c.-32-13T>C
Variant 1 ClinVarID: 4027
Variant 1 CAid: CA116606
Variant 2: NM_000152.5(GAA):c.1396_1397insG (p.Val466GlyfsTer?)
Variant 2 ClinVarID: ?
Variant 2 CAid: CA627699396
Zygosity: Compound heterozygous
ParentalGenotype: N/A
PreviouslyPublished: N/A
#5
Case#: Subject number 5, female, 17 years (report)
DiseaseAssertion: Pompe disease
FamilyInfo: No known family member with PD
CasePresentingHPOs: HP:0002153 (hyperkalemia), HP:0001324 (muscle weakness), HP:0003546 (Exercise intolerance)
CaseHPOFreeText: Biopsy
CaseNotHPOs: HP:0001638 (cardiomyopathy), HP:0001252 (Hypotonia), HP:0003326 (Myalgia), HP:0002015 (dysphagia), HP:0002098 (respiratory distress), HP:0002094 (dyspnoea)
CaseNotHPOFreeText: not asymptomatic
CasePreviousTesting: "Enzymatic activity was detected by fluorometric techniques" "The GAA sequence was performed in all patients whose enzyme activity measured in DBS and lymphocytes was decreased."
glucosidase activity: GAA activity was 0.37 mol/Lh in dried blood spots (normal range >0.75).
Variant 1: NM_000152.5(GAA):c.1328A>T (p.Asp443Val)
Variant 1 ClinVarID: N/A
Variant 1 CAid: CA401366199
Variant 2: NM_000152.5(GAA):c.1328A>T (p.Asp443Val)
Variant 2 ClinVarID: N/A
Variant 2 CAid: CA401366199
Zygosity: homozygous
ParentalGenotype: N/A
PreviouslyPublished: N/A
#9
Case#: Subject number 9, female, 44 years (report)
DiseaseAssertion: Pompe disease
FamilyInfo: No known family member with PD
CasePresentingHPOs: HP:0001638 (cardiomyopathy), HP:0002098 (respiratory distress)
CaseHPOFreeText:
CaseNotHPOs: HP:0002153 (hyperkalemia), HP:0001324 (muscle weakness), HP:0003546 (Exercise intolerance), HP:0001252 (Hypotonia), HP:0003326 (Myalgia), HP:0002015 (dysphagia), HP:0002094 (dyspnoea)
CaseNotHPOFreeText: no biopsy, not asymptomatic
CasePreviousTesting: "Enzymatic activity was detected by fluorometric techniques" "The GAA sequence was performed in all patients whose enzyme activity measured in DBS and lymphocytes was decreased."
glucosidase activity: GAA activity was 0.34 mol/Lh in dried blood spots (normal range >0.75).
Variant 1: NM_000152.5(GAA):c.-32-13T>C
Variant 1 ClinVarID: 4027
Variant 1 CAid: CA116606
Variant 2: NM_000152.5(GAA):c.2819C>A (p.Ser940Ter)
Variant 2 ClinVarID: ?
Variant 2 CAid: CA401327757
Zygosity: Compound heterozygous
ParentalGenotype: N/A
PreviouslyPublished: N/A
#18
Case#: Subject number 18, female, 79 years (report)
DiseaseAssertion: Pompe disease
FamilyInfo: Family member with PD
CasePresentingHPOs:
CaseHPOFreeText: Asymptomatic
CaseNotHPOs: HP:0002153 (hyperkalemia), HP:0001324 (muscle weakness), HP:0003326 (Myalgia), HP:0002015 (dysphagia), HP:0001252 (Hypotonia), HP:0001638 (cardiomyopathy), HP:0002098 (respiratory distress), HP:0003546 (Exercise intolerance), HP:0002094 (dyspnoea)
CaseNotHPOFreeText: no biopsy
CasePreviousTesting: "Enzymatic activity was detected by fluorometric techniques" "The GAA sequence was performed in all patients whose enzyme activity measured in DBS and lymphocytes was decreased."
glucosidase activity: GAA activity was 0.65 mol/Lh in dried blood spots (normal range >0.75).
Variant 1: NM_000152.5(GAA):c.854C>G (p.Pro285Arg)
Variant 1 ClinVarID: 225114
Variant 1 CAid: CA358045
Variant 2: N/A
Variant 2 ClinVarID: N/A
Variant 2 CAid: N/A
Zygosity: Heterozygous
ParentalGenotype: N/A
PreviouslyPublished: N/A
16
Patient16: 16yo
CasePresentingHPOs: HP:0003325, HP:0020038
HPOsFreeText: GAA = 4.5%, BMI = 21.4, fetal origin of right posterior cerebral artery, normal CT
CaseNotHPOs:
NotHPOsFreeText: No cardiovascular risk
CaseAddInfo: 6yr disease duration, variants in trans
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: NM_000152.4(GAA):c.-32-13T>G
Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G
Variant2: NM_000152.3:c.2530_2541del
CAID: CA658795292, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA658795292
gnomAD: n/a
17
Patient17: 65yo
CasePresentingHPOs: HP:0003325, HP:0002093, HP:0002870, HP:0020038, HP:0002637
HPOsFreeText: GAA = 6.8%, smoker, BMI = 27.1, right ventricular trigone retraction due to ischemia
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo: 22yr disease duration, variants in cis
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: NM_000152.4(GAA):c.-32-13T>G
Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G
Variant2: NM_000152.4(GAA):c.1561G>A (p.Glu521Lys)
ClinVar: 4022, https://www.ncbi.nlm.nih.gov/clinvar/variation/4022/
gnomAD: 8.262e-06, http://exac.broadinstitute.org/variant/17-78084749-G-A
20
Patient20: 60yo
CasePresentingHPOs: HP:0003325, HP:0002093, HP:0000822, HP:0002870, HP:0020038
HPOsFreeText: GAA = 11%, BMI = 23.2, subcortical white matter lacunes
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo: 5yr disease duration, variants in cis
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: NM_000152.4(GAA):c.-32-13T>G
Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G
Variant2: NM_000152.4(GAA):c.1561G>A (p.Glu521Lys)
ClinVar: 4022, https://www.ncbi.nlm.nih.gov/clinvar/variation/4022/
gnomAD: 8.262e-06, http://exac.broadinstitute.org/variant/17-78084749-G-A
11
Patient11: 62yo
CasePresentingHPOs: HP:0003325, HP:0002093, HP:0004887, HP:0000822
HPOsFreeText: GAA = 5.7%, smoker, BMI = 22.3, basilar artery fenestration, nucleo-capsular and temporo-insular lacunes
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo: 24yr disease duration, variants in cis
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant: NM_000152.4(GAA):c.-32-13T>G
Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G
Variant2: NM_000152.4(GAA):c.1551+1G>C
ClinVar: 554983, https://www.ncbi.nlm.nih.gov/clinvar/variation/554983/
gnomAD: n/a
Detailed characteristics of these patients
Patient1: female, 29yo, juvenile onset
CasePresentingHPOs:
HPOsFreeText: LOPD, BMI = 19.6;20.3;21, BiPAP use required at last follow-up, WGMS = 3;3;4
CaseNotHPOs: HP:0002355
NotHPOsFreeText:
CaseAddInfo:
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: NM_000152.4(GAA):c.2014C>T (p.Arg672Trp)
ClinVar: 188773, https://www.ncbi.nlm.nih.gov/clinvar/variation/188773/
gnomAD: 0.000008290, http://gnomad.broadinstitute.org/variant/17-78086800-C-T
Variant2: NM_000152.3:c.1703A>T
CAID: CA401369027, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA401369027
gnomAD: n/a
Detailed characteristics of these patients
Patient5: female, 53yo, adult onset
CasePresentingHPOs:
HPOsFreeText: LOPD, BMI = 21.1 / 21.1 / 22.5, WGMS = 3 / 3 / 3
CaseNotHPOs: HP:0002355
NotHPOsFreeText: did not require respiratory support
CaseAddInfo:
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: NM_000152.4(GAA):c.-32-13T>G
Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G
Variant2: NM_000152.4(GAA):c.525delT (p.Glu176Argfs)
ClinVar: 4033, https://www.ncbi.nlm.nih.gov/clinvar/variation/4033/
gnomAD: 0.00009959, http://gnomad.broadinstitute.org/variant/17-78078909-CT-C
31
Case#: Subject number 31(L)
DiseaseAssertion: Late Onset Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CasePreviousTesting: N/A
glucosidase activity: GAA activity #2 (NBS) 0.94 in dried blood spots (>2.10 micromole/L/h is normal).
Variant 1: NM_000152.5(GAA):c.-32-13T>G
Variant 1 ClinVarID: 4027
Variant 1 CAid: CA116606
Variant 2: NM_000152.5(GAA):c.2238G>C
Variant 2 ClinVarID: 265160
Variant 2 CAid: CA8815665
Variant 3: NM_000152.5(GAA):c.2065G>A
Variant 3 ClinVarID: 4030
Variant 3 CAid: CA116612
Zygosity: compound heterozygous
ParentalGenotype: N/A
PreviouslyPublished: N/A
10
Case#: Subject number 10(L)
DiseaseAssertion: Late Onset Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CasePreviousTesting: CK testing: 617 U/L (60-305 U/L is normal), Hex4: 6.6 mmol/mol Creatinine (≤20 mmol/mol Creatinine is normal)
glucosidase activity: GAA activity #1 was 0.84 micromole/L/h and GAA activity #2 (NBS) 0.49 in dried blood spots (>2.10 micromole/L/h is normal). 2.1 in confirmatory testing (>3.88 is normal).
Variant 1: NM_000152.5(GAA):c.1438-1G>C
Variant 1 ClinVarID: 189184
Variant 1 CAid: CA274472
Variant 2: NM_000152.5(GAA):c.-32-13T>G
Variant 2 ClinVarID: 4027
Variant 2 CAid: CA116606
Zygosity: compound heterozygous
ParentalGenotype: N/A
PreviouslyPublished: N/A
30
Case#: Subject number 30(L)
DiseaseAssertion: Late Onset Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CasePreviousTesting: N/A
glucosidase activity: GAA activity #2 (NBS) 1.07 in dried blood spots (>2.10 micromole/L/h is normal).
Variant 1: NM_000152.5(GAA):c.-32-13T>G
Variant 1 ClinVarID: 4027
Variant 1 CAid: CA116606
Variant 2: NM_000152.5(GAA):c.-32-13T>G
Variant 2 ClinVarID: 4027
Variant 2 CAid: CA116606
Zygosity: homozygous
ParentalGenotype: N/A
PreviouslyPublished: N/A
12
Case#: Subject number 12(L)
DiseaseAssertion: Late Onset Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CasePreviousTesting: CK testing: 464 U/L (60-305 U/L is normal)
glucosidase activity: 2.60 in confirmatory testing (>3.88 is normal). AST: 112 (22–71); ALT: 50 (7–50)
Variant 1: NM_000152.5(GAA):c.-32-13T>G
Variant 1 ClinVarID: 4027
Variant 1 CAid: CA116606
Variant 2: NM_000152.5(GAA):c.2238G>C
Variant 2 ClinVarID: 265160
Variant 2 CAid: CA8815665
Zygosity: compound heterozygous
ParentalGenotype: N/A
PreviouslyPublished: N/A
3
Case#: Subject number 3(L)
DiseaseAssertion: Late Onset Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CasePreviousTesting: CK testing: 125 U/L (28-300 U/L is normal), AST: 56 U/L (24-72 U/L is normal), ALT: 49 U/L (17-63 U/L is normal), Hex4: 4.5 mmol/mol Creatinine (≤20 mmol/mol Creatinine is normal)
glucosidase activity: GAA activity #1 was 1.73 micromole/L/h and GAA activity #2 (NBS) 1.08 in dried blood spots (>2.10 micromole/L/h is normal). 3.6 in confirmatory testing (>6.7 is normal).
Variant 1: NM_000152.5(GAA):c.-32-13T>G
Variant 1 ClinVarID: 4027
Variant 1 CAid: CA116606
Variant 2: NM_000152.5(GAA):c.-32-13T>G
Variant 2 ClinVarID: 4027
Variant 2 CAid: CA116606
Zygosity: homozygous
ParentalGenotype: N/A
PreviouslyPublished: N/A
Supplement Table 1)
Patient7: 6yo
CasePresentingHPOs: HP:0001638
HPOsFreeText: rhGAA dosage = 20 QW, independent walker
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo: 12days old at ERT start
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: NM_000152.4(GAA):c.1935C>A (p.Asp645Glu)
ClinVar: 4029, https://www.ncbi.nlm.nih.gov/clinvar/variation/4029/
gnomAD: 0.0001721, http://exac.broadinstitute.org/variant/17-78086721-C-A
Variant2: NM_000152.3:c.1062C>G
CAID: CA401364789, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA401364789
gnomAD: n/a
Variant3: NM_000152.4(GAA):c.1286A>G (p.Gln429Arg)
ClinVar: 284497, https://www.ncbi.nlm.nih.gov/clinvar/variation/284497/
gnomAD: 0.0007528, http://gnomad.broadinstitute.org/variant/17-78082587-A-G
Supplement Table 1)
Patient11: 4yo
CasePresentingHPOs: HP:0001638
HPOsFreeText: rhGAA dosage = 20 EOW, independent walker
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo: 2mo at ERT start
CasePMIDs:
CasePreviousTesting: same a group
CaseGenotypingMethod: same as group
Variant1: NM_000152.3:c.872T>C
CAID: CA401363854, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA401363854
gnomAD: n/a
Variant2: NM_000152.3:c.1798C>T
CAID: CA8815481, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA8815481
gnomAD: 8.669e-06, http://exac.broadinstitute.org/variant/17-78086420-C-T
c.1560C>G
Variant: NM_000152.4:c.1560C>G (p.Asn520Lys)
CAID: CA401367200 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.3%3Ac.1560C%3EG
gnomAD: Not in gnomAD
VariantAddInfo: This variant was declared as novel and found in a patient, but no further information was given.
c.1193del
Variant: NM_000152.4:c.1193delT (p.Leu398Argfs*42)
ClinVar: 371457 https://www.ncbi.nlm.nih.gov/clinvar/variation/371457/
gnomAD: Not in gnomAD
VariantAddInfo: This variant was declared as novel and found in a patient, but no further information was given.
c.1847dup
Variant: NM_000152.4:c.1847dup (p.Asp616Glufs*20)
CAID: CA628018362 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.3%3Ac.1847dup
gnomAD: European (Non-Finnish) 9.142e-6, Overall 4.109e-6 http://gnomad.broadinstitute.org/variant/17-78086468-G-GA
VariantAddInfo: This variant was declared as novel and found in a patient, but no further information was given.
17
Case#: Subject number 17, female, 33 years (report), 14 years (onset), 24 years (diagnosis)
DiseaseAssertion: Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: HP:0000360 (tinnitus)
CaseHPOFreeText: ambulatory
CaseNotHPOs: HP:0009830, HP:0002650, HP:0000939, HP:0000821, HP:0000365, HP:0002617, HP:0100647, HP:0010788, HP:0001638 (peripheral neuropathy, scoliosis, osteoporosis, hypothyroidism, hearing loss, aneurysm, Graves disease, Testicular cancer, cardiomyopathy)
CaseNotHPOFreeText: no infusion reaction, no tracheostomy, not on BiPAP
CasePreviousTesting: “documented deficiency of acid alpha-glucosidase enzyme activity”; on enzyme replacement therapy
Variant 1: NM_000152.5(GAA):c.-32-13T>G (p.Tyr766Ser)
Variant 1 ClinVarID: 4027
Variant 1 CAid: CA116606
Variant 2: NM_000152.5(GAA):c.2104C>T
Variant 2 ClinVarID: 189040
Variant 2 CAid: CA274304
Zygosity: Compound heterozygous
ParentalGenotype: N/A
3
Case#: Subject number 3, male, 56 years (report), 30s years (onset), 48 years (diagnosis)
DiseaseAssertion: Pompe disease
FamilyInfo: N/A ** CasePresentingHPOs**: HP:0000365 (hearing loss), HP:0000360 (tinnitus)
CaseHPOFreeText: ambulatory
CaseNotHPOs: HP:0002617, HP:0000939, HP:0009830, HP:0100647, HP:0010788, HP:0000821, HP:0002650, HP:0001638 (aneurysm, osteoporosis, peripheral neuropathy, Graves disease, Testicular cancer, hypothyroidism, scoliosis, cardiomyopathy)
CaseNotHPOFreeText: No infusion reaction, no tracheostomy, not on BiPAP
CasePreviousTesting: “documented deficiency of acid alpha-glucosidase enzyme activity”; on enzyme replacement therapy
Variant 1: NM_000152.5(GAA):c.-32-13T>G (p.Tyr766Ser)
Variant 1 ClinVarID: 4027
Variant 1 CAid: CA116606
Variant 2: NM_000152.5(GAA):c.2431delC (p.Leu811TrpfsTer?)
Variant 2 ClinVarID: N/A
Variant 2 CAid: CA628018649
Zygosity: Compound heterozygous
ParentalGenotype: N/A
PreviouslyPublished: N/A
16
Case#: Subject number 16, male, 64 years (report), 56 years (onset), 60 years (diagnosis)
DiseaseAssertion: Pompe disease
FamilyInfo: N/A
CasePresentingHPOs:
CaseHPOFreeText: on BiPAP, ambulatory, assistive device (cane)
CaseNotHPOs: HP:0009830, HP:0000360, HP:0002650, HP:0000939, HP:0000821, HP:0000365, HP:0002617, HP:0100647, HP:0010788, HP:0001638 (peripheral neuropathy, tinnitus, scoliosis, osteoporosis, hypothyroidism, hearing loss, aneurysm, Graves disease, Testicular cancer, cardiomyopathy)
CaseNotHPOFreeText: no infusion reaction, no tracheostomy
CasePreviousTesting: “documented deficiency of acid alpha-glucosidase enzyme activity”; on enzyme replacement therapy
Variant 1: NM_000152.5(GAA):c.-32-13T>G (p.Tyr766Ser)
Variant 1 ClinVarID: 4027
Variant 1 CAid: CA116606
Variant 2: NM_000152.5(GAA):c.307T>G
Variant 2 ClinVarID: 92483
Variant 2 CAid: CA220404
Zygosity: Compound heterozygous
ParentalGenotype: N/A
8
Case#: Subject number 8, female, 49 years (report), 20s years (onset), 42 years (diagnosis)
DiseaseAssertion: Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: HP:0000821 (hypothyroidism)
CaseHPOFreeText: ambulatory, assistive device (quad cane, wheelchair)
CaseNotHPOs: HP:0000365, HP:0002650, HP:0000360, HP:0002617, HP:0000939, HP:0009830, HP:0100647, HP:0010788, HP:0001638 (hearing loss, scoliosis, tinnitus, aneurysm, osteoporosis, peripheral neuropathy, Graves disease, Testicular cancer, cardiomyopathy)
CaseNotHPOFreeText: No infusion reaction, no tracheostomy, not on BiPAP
CasePreviousTesting: “documented deficiency of acid alpha-glucosidase enzyme activity”; on enzyme replacement therapy
Variant 1: NM_000152.5(GAA):c.-32-13T>G (p.Tyr766Ser)
Variant 1 ClinVarID: 4027
Variant 1 CAid: CA116606
Variant 2: NM_000152.5(GAA):c.1437+2T>C
Variant 2 ClinVarID: 849313
Variant 2 CAid: CA401366685
Zygosity: Compound heterozygous
ParentalGenotype: N/A
PreviouslyPublished: N/A
5
Case#: Subject number 5, male, 59 years (report), 10 years (onset), 33 years (diagnosis)
DiseaseAssertion: Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: HP:0000365 (hearing loss), HP:0000360 (tinnitus), HP:0000939 (osteoporosis)
CaseHPOFreeText: Tracheostomy, assistive device (wheelchair)
CaseNotHPOs: HP:0002650, HP:0002617, HP:0009830, HP:0100647, HP:0010788, HP:0000821, HP:0001638 (scoliosis, aneurysm, peripheral neuropathy, Graves disease, Testicular cancer, hypothyroidism, cardiomyopathy)
CaseNotHPOFreeText: No infusion reaction, no ambulatory, not on BiPAP
CasePreviousTesting: “documented deficiency of acid alpha-glucosidase enzyme activity”; on enzyme replacement therapy
Variant 1: NM_000152.5(GAA):c.-32-13T>G (p.Tyr766Ser)
Variant 1 ClinVarID: 4027
Variant 1 CAid: CA116606
Variant 2: NM_000152.5(GAA):c.925G>A (p.Gly309Arg)
Variant 2 ClinVarID: 188797
Variant 2 CAid: CA273972
Zygosity: Compound heterozygous
ParentalGenotype: N/A
PreviouslyPublished: N/A
15
Case#: Subject number 15, male, 42 years (report), 15 years (onset), 23 years (diagnosis)
DiseaseAssertion: Pompe disease
FamilyInfo: N/A
CasePresentingHPOs:
CaseHPOFreeText: on BiPAP, ambulatory
CaseNotHPOs: HP:0009830, HP:0000360, HP:0002650, HP:0000939, HP:0000821, HP:0000365, HP:0002617, HP:0100647, HP:0010788, HP:0001638 (peripheral neuropathy, tinnitus, scoliosis, osteoporosis, hypothyroidism, hearing loss, aneurysm, Graves disease, Testicular cancer, cardiomyopathy)
CaseNotHPOFreeText: no infusion reaction, no tracheostomy
CasePreviousTesting: “documented deficiency of acid alpha-glucosidase enzyme activity”; on enzyme replacement therapy
Variant 1: NM_000152.5(GAA):c.-32-13T>G (p.Tyr766Ser)
Variant 1 ClinVarID: 4027
Variant 1 CAid: CA116606
Variant 2: NM_000152.5(GAA):c.1134C>G
Variant 2 ClinVarID: 595469
Variant 2 CAid: CA401365023
Zygosity: Compound heterozygous
ParentalGenotype: N/A
PreviouslyPublished: N/A
new mutation is located in exon 12, c.(1650delG). It creates a shift (p.T551Pfs*27) in the reading frame starting at codon T551. The new reading frame ends in a stop codon 26 positions downstream, which is very likely to result in a truncated protein or loss of protein production.
NM_000152.3:c.1650delG
These newly diagnosed mutations could be pathogenic. For instance, duplications were reported in exon 14 of the GAA gene c.(2040 + 2dup). The duplication of 1 basepair is located adjacent to the highly conserved donor splice site of intron 14. Software analyses (Alamut, version 2.2) predict that an aberrant effect on splicing is possible, resulting in a skip of exon 14
NM_000152.3:c.2040+2dup
P2
Patient2: Female, 1.5mo at diagnosis, 3mo at ERT
CasePresentingHPOs:
HPOsFreeText: classic IOPD, good response to ERT, Pompe muscle pathology score = 2.1(a), 0.5(b), Glycogen = 48.7(a), 2.7(b) Vv(PAS + /mf)%, Larger empty vacuoles = 1.7(a), 5.6(b) Vv (LEV/mf)%, Autophagic vacuoles = 0,15; 0,2 %/mf
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo: biopsy taken from musculus vastus lateralis
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: NM_000152.4(GAA):c.1933G>A (p.Asp645Asn)
ClinVar: 188728, https://www.ncbi.nlm.nih.gov/clinvar/variation/188728/
gnomAD: 2.312e-05, http://exac.broadinstitute.org/variant/17-78086719-G-A
Variant2: NM_000152.3:c.794delG
CAID: CA658795237, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.3%3Ac.794delG
gnomAD: n/a
P5
Patient5: Female, 4.5mo at diagnosis, 5mo at ERT
CasePresentingHPOs:
HPOsFreeText: classic IOPD, poor response to ERT, Pompe muscle pathology score = 1.7, Glycogen = 26.9 Vv(PAS + /mf)%, larger empty vacuoles = 9.9 Vv (LEV/mf)%, Autophagic vacuoles = 2,91 %/mf
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo: homozygous variant, biopsy taken from musculus vastus lateralis
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant: NM_000152.3:c.1456G>C
CAID: CA401366835, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA401366835
gnomAD: n/a
1
Case1: Female, Danish, 38 years report, 25 years onset
CasePresentingHPOs: HP:0008956 (Thigh muscle atrophy)
HPOsFreeText: 6-min walk test achieved 531 m, MRC score is 4/5 (thigh/calf), Forced vital capacity sitting/supine is 2.8/2.2 (L)
NotHPOsFreetext: Not on ERT
GroupGenotypingMethod: Mutation Analysis on the GAA Gene
Variant1: NM_000152.4:c.-32-13T>A
CAID: CA913184742 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA913184742
gnomAD: Not in gnomAD
Variant2: NM_000152.4:c.307T>G (p.Cys103Gly)
ClinVar: 92483 https://www.ncbi.nlm.nih.gov/clinvar/variation/92483/
gnomAD: European (Non-Finnish) 7.874e-6, Overall 3.578e-6 http://gnomad.broadinstitute.org/variant/17-78078692-T-G
CaseAddInfo: Late Onset Pompe Disease
7
Case7: Male, Danish, 20 years report, 1 year onset
HPOsFreeText: MRC score is 4/5 (thigh/calf), Forced vital capacity sitting/supine is 5.6/5.3 (L), Has started ERT
CaseNotHPOs: HP:0008956 (Thigh muscle atrophy)
GroupGenotypingMethod: Mutation Analysis on the GAA Gene
Variant1: NM_000152.4:c.2228A>G (p.Gln743Arg)
CAID: CA401324753 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.2228A%3EG
gnomAD: Not in gnomAD
Variant2: NM_000152.4:c.2237G>C (p.Trp746Ser)
ClinVar: 188484 https://www.ncbi.nlm.nih.gov/clinvar/variation/188484/
gnomAD: African 3.210e-4, Overall 7.089e-5 http://gnomad.broadinstitute.org/variant/17-78090814-G-C
Variant3: NM_000152.4:c.-32-13T>G
ClinVar: 4027 https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G
CaseAddInfo: Late Onset Pompe Disease, Nomenclature indicates Variants 1 and 2 are in cis
4
Case4: Male, French, 65 years report, 55 years onset
HPOsFreeText: 6-min walk test achieved 540 m, MRC score is 5/5 (thigh/calf), Forced vital capacity sitting/supine is 2.7/1.8 (L), On the medications Statin and Allopurinol, Has started ERT
CaseNotHPOs: HP:0008956 (Thigh muscle atrophy)
GroupGenotypingMethod: Mutation Analysis on the GAA Gene
Variant1: NM_000152.4:c.-32-13T>A
CAID: CA913184742 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA913184742
gnomAD: Not in gnomAD
Variant2: NM_000152.4:c.3G>A
CAID: CA401359809 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.3G%3EA
gnomAD: European (Non-Finnish) 8.945e-6, Overall 4.041e-6 http://gnomad.broadinstitute.org/variant/17-78078388-G-A
CaseAddInfo: Late Onset Pompe Disease
Patient Number 1
Case1: Male, 31 years report, 12 years onset, Algeria, African
CasePresentingHPOs: HP:0003749, HP:0002355, HP:0003551, HP:0008997, HP:0003484, HP:0002875, HP:0002315, HP:0002938, HP:0002515, HP:0008994, HP:0009129, HP:0007210, HP:0008981, HP:0006844, HP:0002091, HP:0003236, HP:0003198, HP:0003560 (Pelvic girdle muscle weakness, Difficulty walking, Difficulty climbing stairs, Proximal muscle weakness in upper limbs, Upper limb muscle weakness, Exertional dyspnea, Headache, Lumbar hyperlordosis, Waddling gait, Proximal muscle weakness in lower limbs, Upper limb amyotrophy, Lower limb amyotrophy, Calf muscle hypertrophy, Absent patellar reflexes, Restrictive lung disease, Increased serum CK, Myopathic changes, Muscular dystrophy)
HPOsFreeText: Severe proximal weakness of paraspinal muscles, At grade 3 of Vignos and Walton scales, Serum CK activity was 4 times the normal value and AST and ALT were 3 times the normal value, GAA activity measured in leukocytes was reduced to about 6% of control values, Became wheelchair-dependent at the age of 27 years
CaseNotHPOs: HP:0003115, HP:0003116, HP:0001270, HP:0001290, HP:0002240, HP:0001640 (Abnormal ECG, Abnormal echocardiography, Motor delay, Generalized hypotonia, Hepatomegaly, Cardiomegaly)
CaseAddInfo: Proband had one affected parental cousin, Patient 2, who died from respiratory problems in 2008
Patient Number 5
Case5: Female, 11 months report and onset, Algeria, African
CasePresentingHPOs: HP:0002098, HP:0002883, HP:0000961, HP:0030829, HP:0001290, HP:0003236, HP:0003198, HP:0002878 (Respiratory distress, Rapid breathing, Cyanosis, Abnormal breath sound, Generalized Hypotonia, Increased serum CK, Myopathy, Respiratory failure)
HPOsFreeText: Intercostal and subcostal retraction, Diffuse infiltrative process involving the left lung field, CK rate was 3 times the normal value and AST and ALT were 2 times the normal value, GAA activity was deficient
CaseNotHPOs: HP:0030148, HP:0011675, HP:0001315, HP:0001291, HP:0003115 (Heart murmur, Arrhythmia, Decreased/absent deep tendon reflexes, Cranial nerve abnormality, Abnormal ECG)
CaseAddInfo: Proband was the second born child of healthy consanguineous parents, Pregnancy was uneventful,
c.1075G > T(p.Gly359*)
Case1
HPOsFreeText: See Group Phenotypes
CasePreviousTesting: Sanger sequencing
CaseMethod1: Sanger sequencing and PCR Amplification
CaseMethod2: Whole Exome Sequencing (WES)
CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.
Variant: NM_000152.4:c.1075G>T (p.Gly359Ter)
ClinVar: 420101 https://www.ncbi.nlm.nih.gov/clinvar/variation/420101/
gnomAD: Not in gnomAD
CaseAddInfo: Infantile Onset Pompe Disease, Patient is homozygous for this variant
c.2481+102_2646+31del (p.Gly828_Asn882del)
Case39
HPOsFreeText: See Group Phenotypes
CasePreviousTesting: Sanger sequencing
CaseMethod1: Sanger sequencing and PCR Amplification
CaseMethod2: Whole Exome Sequencing (WES)
CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.
Variant1: NM_000152.4:c.2481+102_2646+31del (p.Gly828_Asn882del) (exon 18 del)
ClinVar: 4031 https://www.ncbi.nlm.nih.gov/clinvar/variation/4031/
gnomAD: Not in gnomAD
Variant2: NM_000152.4:c.525delT (p.Glu176Argfs*45)
CAID: 4033 https://www.ncbi.nlm.nih.gov/clinvar/variation/4033/
gnomAD: European (Non-Finnish) 1.880e-4, Overall 9.959e-5 http://gnomad.broadinstitute.org/variant/17-78078909-CT-C
CaseAddInfo: Infantile Onset Pompe Disease, 1 more patient has the same genotype
c.-32-17_-32-10delins TCCCTGCTGAGCCTCCTACAGGCCTCCCGC
Case49
HPOsFreeText: See Group Phenotypes
CasePreviousTesting: Sanger sequencing
CaseMethod1: Sanger sequencing and PCR Amplification
CaseMethod2: Whole Exome Sequencing (WES)
CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.
Variant1: NM_000152.4:c.-32-17_-32-10delins TCCCTGCTGAGCCTCCTACAGGCCTCCCGC
CAID: CA913184750 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA913184750
gnomAD: Not in gnomAD
Variant2: NM_000152.4:c.1447G>A (p.Gly483Arg)
ClinVar: 285157 https://www.ncbi.nlm.nih.gov/clinvar/variation/285157/
gnomAD: African 6.170e-5, Overall 7.972e-6 http://gnomad.broadinstitute.org/variant/17-78084535-G-A
CaseAddInfo: Infantile Onset Pompe Disease
c.2560C > T(p.Arg854*)
Case77
HPOsFreeText: See Group Phenotypes
CasePreviousTesting: Sanger sequencing
CaseMethod1: Sanger sequencing and PCR Amplification
CaseMethod2: Whole Exome Sequencing (WES)
CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.
Variant1: NM_000152.4:c.2560C>T (p.Arg854*)
ClinVar: 4034 https://www.ncbi.nlm.nih.gov/clinvar/variation/4034/
gnomAD: African 1.891e-3, Overall 2.090e-4 http://gnomad.broadinstitute.org/variant/17-78092070-C-T
Variant2: NM_000152.4:c.-32-13T>G
ClinVar: 4027 https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G
CaseAddInfo: Adult Late Onset Pompe Disease
c.1327-2A > C
Case30
HPOsFreeText: See Group Phenotypes
CasePreviousTesting: Sanger sequencing
CaseMethod1: Sanger sequencing and PCR Amplification
CaseMethod2: Whole Exome Sequencing (WES)
CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.
Variant: NM_000152.4:c.1327-2A>C
CAID: CA401366173 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.1327-2A%3EC
gnomAD: Not in gnomAD
CaseAddInfo: Infantile Onset Pompe Disease, Patient is homozygous for this variant
c.1655T > C(p.Leu552Pro)
Case53
HPOsFreeText: See Group Phenotypes
CasePreviousTesting: Sanger sequencing
CaseMethod1: Sanger sequencing and PCR Amplification
CaseMethod2: Whole Exome Sequencing (WES)
CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.
Variant: NM_000152.4:c.1655T>C (p.Leu552Pro)
ClinVar: 279811 https://www.ncbi.nlm.nih.gov/clinvar/variation/279811/
gnomAD: European (Non-Finnish) 7.053e-5, Overall 3.188e-5 http://gnomad.broadinstitute.org/variant/17-78085800-T-C
CaseAddInfo: Juvenile Late Onset Pompe Disease
PD16
Patient16: Male, Northern China
CasePresentingHPOs:
HPOsFreeText: IOPD
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo:
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: NM_000152.4(GAA):c.2662G>T (p.Glu888Ter)
ClinVar: 578595, https://www.ncbi.nlm.nih.gov/clinvar/variation/578595/
gnomAD: 1.65e-05, http://exac.broadinstitute.org/variant/17-78092467-G-T
Variant2: NM_000152.3:c.1597T>G
CAID: CA401367282, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA401367282
gnomAD: n/a
PD03
Patient3: Male, northern China
CasePresentingHPOs:
HPOsFreeText: IOPD
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo:
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: NM_000152.3:c.2024A>G
CAID: CA401370120, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA401370120
gnomAD: n/a
Variant2: NM_000152.4(GAA):c.2132C>G (p.Thr711Arg)
ClinVar: 381006, https://www.ncbi.nlm.nih.gov/clinvar/variation/381006/
gnomAD: 0.0001488, http://exac.broadinstitute.org/variant/17-78087108-C-G
PD22
Patient22: Female, Southern China
CasePresentingHPOs:
HPOsFreeText: IOPD
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo:
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: NM_000152.3:c.1241del
CAID: CA913184736, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA913184736
gnomAD: n/a
Variant2: NM_000152.4(GAA):c.2662G>T (p.Glu888Ter)
ClinVar: 578595, https://www.ncbi.nlm.nih.gov/clinvar/variation/578595/
gnomAD: 1.65e-05, http://exac.broadinstitute.org/variant/17-78092467-G-T
Clinical laboratory experience of blood CRIM testing in infantile Pompe disease
PMID: 26693141
Gene: GAA
P4a
Patient4: Male, 50yo
CasePresentingHPOs: HP:0003077, HP:0005978
HPOsFreeText: LOPD
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo: 5yr follow-up MRI, 18yr disease duration, ERT lasted 130mo
CasePMIDs: PMID: 25614309
CasePreviousTesting: same as group
CaseGenotypingMethod: same as grou
Variant1: NM_000152.4(GAA):c.-32-13T>G
Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G
Variant2: NM_000152.3:c.1495T>A
CAID: CA198789, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA198789
gnomAD: n/a
P3a
Patient3: Male, 50yo
CasePresentingHPOs: HP:0003077, HP:0000822
HPOsFreeText: LOPD
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo: 5yr follow-up MRI, 40yr disease duration, ERT lasted for 116mo
CasePMIDs: PMID: 25614309
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: NM_000152.4(GAA):c.-32-13T>G
Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G
Variant2: c.2136-7delGT no ClinVar, no CAID
P18
Patient18: Male, 49yo
CasePresentingHPOs:
HPOsFreeText: LOPD
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo: 13yr disease duration, ERT lasted 84mo
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: NM_000152.4(GAA):c.-32-13T>G
Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G
Variant2: NM_000152.3:c.794delG
CAID: CA658795237, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.3%3Ac.794delG
gnomAD: n/a
8
Patient8: Female, 8 year onset
CasePresentingHPOs: HP:0001324 (Muscle Weakness)
HPOsFreeText: GAA activity 3.2% from dried blood spot
CaseNotHPOs: HP:0002098, HP:0001640, HP:0002240 (Respiratory distress, Cardiomegaly, Hepatomegaly)
NotHPOsFreeText: No wheelchair needed, Respiratory Assistance not needed
CaseAddInfo: LOPD
5
Patient5: Female, 4 years report, 10 months onset
CasePresentingHPOs: HP:0001640, HP:0002240, HP:0001324 (Cardiomegaly, Hepatomegaly, Muscle weakness)
HPOsFreeText: GAA activity 2.4% from leukocyte
CaseNotHPOs: HP:0002098 (Respiratory distress)
NotHPOsFreeText: No wheelchair needed, Respiratory Assistance not needed
CaseAddInfo: IOPD
27
Patient27: Female, 9 years report, 7 years onset
CasePresentingHPOs: N/A
HPOsFreeText: GAA activity 5.5% from leukocyte
CaseNotHPOs: HP:0002098, HP:0001324, HP:0001640, HP:0002240 (Respiratory distress, Muscle weakness, Cardiomegaly, Hepatomegaly)
NotHPOsFreeText: No wheelchair needed, Respiratory Assistance not needed
CaseAddInfo: LOPD
37
Patient37: Male, 25 years report, 8 year onset
CasePresentingHPOs: HP:0001324, HP:0002098 (Muscle weakness, Respiratory distress)
HPOsFreeText: GAA activity 9% from leukocyte, Wheelchair needed, Respiratory Assistance needed
CaseNotHPOs: HP:0001640, HP:0002240 (Cardiomegaly, Hepatomegaly)
NotHPOsFreeText: N/A
CaseAddInfo: LOPD
it has also been shown to have a broad spectrum of variability in the decline of locomotive and respiratory function, even in patients with the same genotype, as enzyme activity varies per patient and per tissue [16], [17], [21].
NM_000152.4(GAA):c.-32-13T>G
Subject II-6
Subject II-6: female, 56yo
CasePresentingHPOs: HP:0000822, HP:0003701, HP:0001611, HP:0003691, HP:0003700, HP:0009023, HP:0003307, HP:0002515, HP:0040081, HP:0003458
HPOsFreeText: altered DBS, treated with beta-blockers, occasional cramping of lower limbs, muscle atrophy of temporal, deltoids, and thigh muscle extensors, muscle strength was 5/5 proximal and distal for upper limbs and distal for lower limbs, and 4/5 on hip extension, diminished biceps, triceps, patellar, and ankle jerk reflexes. Intact pain, temperature, vibration, proprioception, and coordination. CK = 86 IU/L, AST = 33 IU/L, reduced GAA activity, reduced duration and amplitude of motor unit action potentials (mainly on thigh extensors), normal muscle biopsy
CaseNotHPOs: HP:0001291, HP:0002015, HP:0001618, HP:0003391, HP:0003487
NotHPOsFreeText: no Hoffmann sign, paraspinal complex repetitive discharges
CaseAddInfo: This patient's 5 daughters had DBS and GAA sequencing evaluations, only 2 (III-9 and III-10) had altered DBS and carried GAA variants
CasePMIDs:
CasePreviousTesting: DBS, EMG, muscle biopsy from thigh extensors
CaseGenotypingMethod: GAA genotyping
Variant1: NM_000152.4(GAA):c.-32-13T>G
Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G
Variant2: NM_000152.4(GAA):c.2560C>T (p.Arg854Ter)
ClinVar: 4034, https://www.ncbi.nlm.nih.gov/clinvar/variation/4034/
gnomAD: 0.0002090, http://gnomad.broadinstitute.org/variant/17-78092070-C-T
PD/Pathogenic-6
CasePD/Pathogenic-6: 4 weeks diagnosis
HPOsFreeText: GAA activity 8.8 (nmol · h−1 · mg−1), Mean percentage of normal 12.3%
GenotypingMethod: Newborn Screening Panels
Variant1: NM_000152.4:c.1726G>A (p.Gly576Ser)
ClinVar: 92467 https://www.ncbi.nlm.nih.gov/clinvar/variation/92467/
gnomAD: East Asian 0.1427, Overall 0.01700 http://gnomad.broadinstitute.org/variant/17-78085871-G-A
Variant2: NM_000152.4:c.2065G>A (p.Glu689Lys)
ClinVar: 4030 https://www.ncbi.nlm.nih.gov/clinvar/variation/4030/
gnomAD: East Asian 0.2355, Overall 0.05524 http://gnomad.broadinstitute.org/variant/17-78087041-G-A
Chromosomal code not provided
Variant3: NP_000143.2:p.N87Tfs*55
ClinVar: N/A
gnomAD: N/A
CaseAddInfo: Patient has one pseudodeficency allele and one pathogenic allele, Nomenclature claims Variant 1 and 2 are in cis
PD/Pathogenic-10
CasePD/Pathogenic-10: 2 weeks diagnosis
HPOsFreeText: GAA activity 5.5 (nmol · h−1 · mg−1), Mean percentage of normal 7.8%
GenotypingMethod: Newborn Screening Panels
Variant1: NM_000152.4:c.271G>A (p.Asp91Asn)
ClinVar: 4020 https://www.ncbi.nlm.nih.gov/clinvar/variation/4020/
gnomAD: European (Non-Finnish) 0.03291, Overall 0.02049 http://gnomad.broadinstitute.org/variant/17-78078656-G-A
Variant2: NM_000152.4:c.2161G>T (p.Glu721Ter)
CAID: CA401370611 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.2161G%3ET
gnomAD: Not in gnomAD
Variant3: NM_000152.4:c.2237G>T (p.Trp746Leu)
ClinVar: 284776 https://www.ncbi.nlm.nih.gov/clinvar/variation/284776/
gnomAD: European (Non-Finnish) 1.244e-4, Overall 7.798e-5 http://gnomad.broadinstitute.org/variant/17-78090814-G-T
CaseAddInfo: Patient has one pseudodeficency allele and one pathogenic allele, Nomenclature claims Variant 2 and 3 are in cis
LOPD-15
CaseLOPD-15: 2 weeks diagnosis
HPOsFreeText: GAA activity 3.6 (nmol · h−1 · mg−1), Mean percentage of normal 5.1%
GenotypingMethod: Newborn Screening Panels
Variant1: NM_000152.4:c.271G>A (p.Asp91Asn)
ClinVar: 4020 http://www.ncbi.nlm.nih.gov/clinvar/variation/4020
gnomAD: European (Non-Finnish) 0.03291, Overall 0.02049 http://gnomad.broadinstitute.org/variant/17-78078656-G-A
Chromosomal code not provided
Variant2: NP_000143.2:p.V740Gfs*55
ClinVar: N/A
gnomAD: N/A
Chromosomal code not provided and typo likely
Variant3: NP_000143.2:p.T234 mol/L
ClinVar: N/A
gnomAD: N/A
CaseAddInfo: Late Onset Pompe Disease, Nomenclature claims Variant 1 and 2 are in cis
14
Case#: Patient 14, male
CasePresentingHPOs: HP:0003236, HP:0003325
CaseAddInfo: 50yo at onset, 66yo at diagnosis
VariantAllele1: NM_000152.4(GAA):c.-32-13T>G
ClinVar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G
VariantAllele2: c.2219-20dTG, p.Val740GfsX55 No ClinVar or CAID
6
Case#: Patient 6, female
CasePresentingHPOs: HP:0003236, HP:0003325
CaseAddInfo: 55yo at onset, 59yo at diagnosis
VariantAllele1: NM_000152.4(GAA):c.-32-13T>G
ClinVar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G
VariantAllele2: NM_000152.4(GAA):c.1561G>A (p.Glu521Lys)
ClinVar: 4022, https://www.ncbi.nlm.nih.gov/clinvar/variation/4022/
gnomAD: 8.262e-06, http://exac.broadinstitute.org/variant/17-78084749-G-A
1
Case# Patient 1, male
CasePresentingHPOs: HP:0003236
CaseAddInfo: 14yo at onset, 16 at diagnosis
VariantAllele1: NM_000152.4(GAA):c.-32-13T>G
ClinVar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G
VariantAllele2: NM_000152.4(GAA):c.1655T>C (p.Leu552Pro
ClinVar: 279811; https://www.ncbi.nlm.nih.gov/clinvar/variation/279811/
gnomAD: 1.663e-05; http://exac.broadinstitute.org/variant/17-78085800-T-C
1
Case#: Patient 1, female, 2.5 months of age at diagnosis, Hispanic
DiseaseAssertion: Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: HP:0001638, HP:0032988, HP:0001252, HP:0001270, HP:0002015, HP:0012378
(Cardiomyopathy, Persistent head lag, Muscular hypotonia, Motor delay, Dysphagia, Fatigue)
CaseHPOFreeText: NG tube feeding was left after Enzyme Replacement Therapy (ERT).
Cardiac status at base line was 160 LVMI g/m^2, after ERT IT WAS 81 LVMI g/m^2
Patient needed oxygen at baseline, no respiratory support at ERT.
one episode of Infusion Associated Reactions (IARs) to ERT.
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CasePreviousTesting:
Variant 1: NM_000152.5(GAA):c.2608C>T (p.Arg870Ter)
ClinVar: 189009
CAID: CA274250
gnomAD: Highest population MAF= 0.00004888 (European non-Finnish)
ParentalGenotype:N/A
PreviouslyPublished:N/A
(Supplementary Table S3 shows details, IgG trajectories, and outcomes).
Patient 13 - IOPD - homozygous
Variant: NM_000152.3:c.1195-18_2190-20del
CAID: CA913184754, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA913184754
gnomAD: n/a
Ten patients received concomitant immunomodulation (detailed in Supplementary Table S4); six were genotype-predicted as CRIM-negative, three were CRIM-positive, and one lacked genotype data.
Patient 3
Variant1: NM_000152.3:c.2481+102_2646+31del
CAID: CA658795291, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.3%3Ac.2481%2B102_2646%2B31del
gnomAD: n/a
Variant2: NM_000152.4(GAA):c.307T>G (p.Cys103Gly)
ClinVar: 92483, https://www.ncbi.nlm.nih.gov/clinvar/variation/92483/
gnomAD: n/a
PATIENT 1
Case#: Patient 1, woman, 58 years old, ethnicity unknown
DiseaseAssertion:Pompe disease
Was also misdiagnosed with adult-onset spinal muscular atrophy (SMA)
FamilyInfo: No family history of muscle disease
CasePresentingHPOs: HP:0003701, HP:0100284
(Proximal muscle weakness, EMG myotonic discharges)
CaseHPOFreeText: Denervation atrophy from a muscle biopsy
Weakness of hip flexion 2–3/5, hip abduction 2/5, and hip adduction 2/5
Myotonic discharges were in the lumbar paraspinals, vastus medialis, and tensor fasciae latae muscles.
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CasePreviousTesting: GAA enzyme activity assay was 1 pmol/punch/h (normal range 10–49 pmol/punch/h)
Her creatine kinase (CK) level at presentation had been elevated as high as 429 U/L (normal range 45–145)
Found with two mutations in the GAA gene
Variant: NM_000152.5(GAA):c.-32-13T>G
ClinVar: 4027
CAID: CA116606
gnomAD: Highest population MAF= 0.005541 (Ashkenazi Jewish)
Variant: NM_000152.5(GAA):c.525del (p.Glu176fs) Double check this variant
ClinVar: 4033
CAID: CA220406
gnomAD: N/A
ParentalGenotype:N/A
Previously Published: N/A
24/F
Patient24: Female
CasePresentingHPOs: HP:0000365
HPOsFreeText: CRIM positive, heart normalization
CaseNotHPOs: HP:0004887, HP:0025156, HP:0002355, HP:0002546, HP:0001371
NotHPOsFreeText: infusion associated reaction
CaseAddInfo: variants in trans, symptom onset at 2yo, diagnosis at 3yo, ERT at 4yo
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: NM_000152.4(GAA):c.1933G>A (p.Asp645Asn)
ClinVar: 188728, https://www.ncbi.nlm.nih.gov/clinvar/variation/188728/
gnomAD: 0.000008250, http://gnomad.broadinstitute.org/variant/17-78086719-G-A
Variant2: NM_000152.3:c.1822C>T
CAID: CA8815488, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.3%3Ac.1822C%3ET
gnomAD: 0.00001806, http://gnomad.broadinstitute.org/variant/17-78086444-C-T
27/M
Patient27: Male
CasePresentingHPOs: HP:0000365
HPOsFreeText: CRIM positive, Anti-rh GGA antibodies maximum titer = ≤ 1:400, moderate periventricular white matter abnormalities (hypomyelination), progressive deterioration of MRI parameters
CaseNotHPOs: HP:0004887, HP:0025156, HP:0002355, HP:0002546, HP:0001371
NotHPOsFreeText: infusion associated reaction, heart normalization
CaseAddInfo: variants in trans, symptom onset at birth, diagnosis at 3yo, ERT at 4yo
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: NM_000152.4(GAA):c.1465G>A (p.Asp489Asn)
ClinVar: 92465, https://www.ncbi.nlm.nih.gov/clinvar/variation/92465/
gnomAD: 0.00001195, http://gnomad.broadinstitute.org/variant/17-78084553-G-A
Variant2: NM_000152.3:c.40_47del
CAID: CA913184761, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA913184761
gnomAD: n/a
4
Patient4: Female
CasePresentingHPOs: HP:0004887, HP:0002194, HP:0001522
HPOsFreeText: ERT dosage = 20 mg/kg/2 w, able to hold objects, CRIM negative
CaseNotHPOs:
NotHPOsFreeText: no reversal of HCM
CaseAddInfo: Symptom onset and diagnosis at 2mo, ERT at 3.5mo, ERT lasted for 8mo, ventilation required at 11mo, died at 12mo
CasePMIDs: 22252923, 27629047
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant: NM_000152.3:c.1657C>T
CAID: CA401368835, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.3%3Ac.1657C%3ET
gnomAD: n/a
14
Case14: Female, 15 years onset, 16 years diagnosis, Italy
HPOsFreeText: See Group Phenotypes, ERT started at 16, GAA Activity at ~8 pmol/min/mg before ERT and ~12 after
GroupGenotypingMethod: PCR Amplification and GAA Gene Sequencing
Variant1: NM_000152.4:c.-32-13T>G
ClinVar: 4027 https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G
Variant2: NM_000152.4:c.1927G>A (p.Gly643Arg)
ClinVar: 4023 https://www.ncbi.nlm.nih.gov/clinvar/variation/4023/
gnomAD: European (Non-Finnish) 3.667e-5, Overall 2.479e-5 http://gnomad.broadinstitute.org/variant/17-78086713-G-A
CaseAddInfo: Late Onset Pompe Disease
20
Case#: Subject number 20, female, 29 years (diagnosis), 40 years (baseline visit), 40 years (ERT), 39 (age at ventilation)
DiseaseAssertion: Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: HP:0001324 (Muscle Weakness), HP:0002098 (respiratory distress)
CaseHPOFreeText: mechanical ventilation at Baseline Visit, mechanical ventilation at last visit
CaseNotHPOs: HP:0003236 (Elevated circulating creatine kinase concentration), HP:0002870 (obstructive sleep apnea)
CaseNotHPOFreeText:
CasePreviousTesting: "reduced enzymatic activity on fibroblasts, blood leukocytes or skeletal muscle and/or the presence of two known mutations in the GAA gene"
PreviouslyPublished: N/A
26
Case#: Subject number 26, male, 35 years (diagnosis), 51 years (baseline visit), 51 years (ERT), 49 (age at ventilation)
DiseaseAssertion: Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: HP:0001324 (Muscle Weakness), HP:0002098 (respiratory distress)
CaseHPOFreeText: mechanical ventilation at Baseline Visit, mechanical ventilation at last visit
CaseNotHPOs: HP:0003236 (Elevated circulating creatine kinase concentration), HP:0002870 (obstructive sleep apnea)
CaseNotHPOFreeText:
CasePreviousTesting: "reduced enzymatic activity on fibroblasts, blood leukocytes or skeletal muscle and/or the presence of two known mutations in the GAA gene"
PreviouslyPublished: N/A
15
Case#: Subject number 15, female, 35 years (diagnosis), 51 years (baseline visit), 46 years (ERT), 46 (ventilation)
DiseaseAssertion: Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: HP:0001324 (Muscle Weakness), HP:0002098 (respiratory distress)
CaseHPOFreeText: mechanical ventilation at Baseline Visit, mechanical ventilation at last visit
CaseNotHPOs: HP:0003236 (Elevated circulating creatine kinase concentration), HP:0002870 (obstructive sleep apnea)
CaseNotHPOFreeText:
CasePreviousTesting: "reduced enzymatic activity on fibroblasts, blood leukocytes or skeletal muscle and/or the presence of two known mutations in the GAA gene"
PreviouslyPublished: N/A
24
Case#: Subject number 24, female, 42 years (diagnosis), 57 years (baseline visit), 55 years (ERT), 54 (age at ventilation)
DiseaseAssertion: Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: HP:0001324 (Muscle Weakness), HP:0002098 (respiratory distress)
CaseHPOFreeText: mechanical ventilation at Baseline Visit, mechanical ventilation at last visit
CaseNotHPOs: HP:0003236 (Elevated circulating creatine kinase concentration), HP:0002870 (obstructive sleep apnea)
CaseNotHPOFreeText:
CasePreviousTesting: "reduced enzymatic activity on fibroblasts, blood leukocytes or skeletal muscle and/or the presence of two known mutations in the GAA gene"
PreviouslyPublished: N/A
27
Case#: Subject number 27, male, 35 years (diagnosis), 51 years (baseline visit)
DiseaseAssertion: Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: HP:0001324 (Muscle Weakness)
CaseHPOFreeText:
CaseNotHPOs: HP:0003236 (Elevated circulating creatine kinase concentration), HP:0002870 (obstructive sleep apnea), HP:0002098 (respiratory distress)
CaseNotHPOFreeText: no mechanical ventilation at Baseline Visit, no mechanical ventilation at last visit
CasePreviousTesting: "reduced enzymatic activity on fibroblasts, blood leukocytes or skeletal muscle and/or the presence of two known mutations in the GAA gene"
PreviouslyPublished: N/A
8
Patient8: Female, 41yo at diagnosis, 48yo at ERT
CasePresentingHPOs:
HPOsFreeText: anti rh-GAA antibodies titre = 1:1600, enzyme (μmol/g/h) = 0.23 (2-10), mobility aid required before and after ERT
CaseNotHPOs:
NotHPOsFreeText: NIV not required
CaseAddInfo: 7yr disease duration, variants in trans
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: NM_000152.3:c.482_483del
CAID: CA8814879, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA8814879
gnomAD: 1.729e-05, http://exac.broadinstitute.org/variant/17-78078864-TCC-T
Variant2: NM_000152.4(GAA):c.692+5G>T
ClinVar: 562532, https://www.ncbi.nlm.nih.gov/clinvar/variation/526532/
gnomAD: 8.596e-06, http://exac.broadinstitute.org/variant/17-78079698-G-T
4
Case#: Patient 4, male, diagnosed 2015 (not given age of diagnosis), age 42 during study period
DiseaseAssertion: Pompe Disease
FamilyInfo: None given
CasePresentingHPOs: None given
CaseHPOFreeText: None given
CaseNotHPOs: None given
CaseNotHPOFreeText: None given
CasePreviousTesting: None given
Variant 1: NM_000152.5:c.-32-13T>A (unclear variant nomenclature)
Variant 1 ClinVarID: N/A
Variant 1 CAid: CA913184742
Variant 2: NM_000152.5:c.525del
Variant 2 ClinVarID: 4033
Variant 2 CAid: CA220406
ParentalGenotype: Not provided
3
Case#: Patient 3, female, diagnosed 2015 (not given age of diagnosis), age 40 during study period
DiseaseAssertion: Pompe Disease
FamilyInfo: None given
CasePresentingHPOs: None given
CaseHPOFreeText: None given
CaseNotHPOs: None given
CaseNotHPOFreeText: None given
CasePreviousTesting: None given
Variant 1: NM_000152.5:c.-32-13T>G (unclear variant nomenclature, homozygous)
Variant 1 ClinVarID: 4027
Variant 1 CAid: CA116606
ParentalGenotype: Not provided
3
Case3: Female, 22 years diagnosis, 19 years onset
CasePresentingHPOs: HP:0009073, HP:0003198 (Progressive proximal muscle weakness, Myopathy)
HPOsFreeText: Electromyography showed myogenic damage, Vacuolar myopathy, Serum CK is 73.5 U/L
2
Case#: Patient 2
DiseaseAssertion: Pompe Disease
FamilyInfo: None given
CasePresentingHPOs: None
CaseHPOFreeText: None
CaseNotHPOs: None
CaseNotHPOFreeText: None
CasePreviousTesting: Single gene sequencing with Ion Torrent Persional Genome Machine
Glucosidase activity: 0.0 nmol 5MU/hr/mL
Variant 1: NM_000152.5:c.596A>G
Variant 1 ClinVarID: 92486
Variant 1 CAid: CA145785
Variant 2: NM_000152.5:c.668G>A
Variant 2 ClinVarID: 92488
Variant 2 CAid: CA145791
ParentalGenotype: Not provided
23
Case#: P 23, Female, 4.7 months old when started ERT (45.8months old when last reported), German
DiseaseAssertion: Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: HP:0001639 , HP:0001252 , HP:0003701, HP:0006532, HP:0002650
(Hypertrophic cardiomyopathy, Muscular hypotonia, Proximal muscle weakness, Recurrent Pneumonia, Scoliosis)
CaseHPOFreeText: Scoliosis and recurrent pneumonia were complications during ERT
No motor activity achieved
Requiered ventilation and tube feeding
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CasePreviousTesting: N/A
Variant: NM_000152.3:c.1456G>C (p.Ala486Pro)
ClinVar: N/A
CAID: CA401366835
gnomAD: N/A
ParentalGenotype: Both the paternal and maternal allele carried the NM_000152.3:c.1456G>C Variant
PreviouslyPublished:N/A
22
Case#: P 22, Female, 0.2 months old when started ERT (47.0 months old when last reported), German
DiseaseAssertion: Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: HP:0001639 , HP:0001252 , HP:0003701, HP:0001371
(Hypertrophic cardiomyopathy, Muscular hypotonia, Proximal muscle weakness, Flexion contracture )
CaseHPOFreeText: Flexion contractures were a complication during ERT
CaseNotHPOs: N/A
CaseNotHPOFreeText: No tube feeding nor ventilation needed
CasePreviousTesting: CRIM status is unknown
Antibody titer is 1:1.800
Variant 1: NM_000152.3:c.2004C>A
ClinVar: N/A
CAID: CA401370054
gnomAD: N/A
Variant: c.541545delTTAC
ClinVar: N/A
CAID: N/A
gnomAD: N/A
ParentalGenotype: Maternal allele carried the c.2004 C>A Variant
The paternal allele carried the c.541545delTTAC
PreviouslyPublished: N/A
Patient 2 was a 29-year old Caucasian male
Patient2: female, 29 yo, Caucasian
CasePresentingHPOs: HP:0003724, HP:0008988, HP:0003691, HP:0003391, HP:0003551, HP:0040081, HP:0002910, HP:0003557, HP:0100295, HP:0100295, HP:0009051, HP:0004356, HP:0002111
HPOsFreeText: paravertebral muscle atrophy, atrophies with paresis grade of 3-4 MRC, cannot stand from squatting position, impaired overhead work, CK = 1390 U/l, AST = 65 U/l, ALAT = 72 U/L, symmetrical atrophy of thigh muscle, fatty deposits in m. adductor magnus, flause signal elevation in the mm. semimembranosus and mm. biceps femoris bilateral, reticulation in the proximal vastus intermedius and vastus lateralis, vacuolated muscle fibres, PAS-positive glycogen storage with enhanced lysosomal activity in the PAS staining, increased lysosomal activity, GAA activity = 0.22nmol/spot x 21hrs
CaseNotHPOs: HP:0001639
CaseAddInfo:
CasePreviousTesting: MRI of thigh muscle, muscle biopsy of mm. vastus lateralis, hematoxylin and eosin stain, Peri acid-Schiff reaction, Acid phosphatase staining, transthoracic echocardiogram, respiratory function test
CaseGenotypingMethod: Sanger Sequencing
Variant: NM_000152.4(GAA):c.-32-13T>G
Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G
Case32: Female, 45 years report
HPOsFreeText: ERT not started, 6 Minute Walking Test at 533 meters, Forced Vital Capacity at 77%
GenotypingMethod: GAA Gene Sequencing
Variant1: NM_000152.4:c.-32-13T>G
ClinVar: 4027 http://www.ncbi.nlm.nih.gov/clinvar/variation/4027
gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G
Variant2: NM_000152.4:c.1888+1G>A
CAID: CA8815511 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.1888%2B1G%3EA
gnomAD: European (Non-Finnish) 9.843e-6, Overall 4.375e-6 http://gnomad.broadinstitute.org/variant/17-78086511-G-A
CaseAddInfo: Late Onset Pompe Disease
Case9: Female, 34 years report
HPOsFreeText: 6 years of ERT completed, 6 Minute Walking Test at 452 meters, Forced Vital Capacity at 76%
GenotypingMethod: GAA Gene Sequencing
Variant1: NM_000152.4:c.1655T>C (p.Leu552Pro)
ClinVar: 279811 https://www.ncbi.nlm.nih.gov/clinvar/variation/279811/
gnomAD: European (Non-Finnish) 7.053e-5, Overall 3.188e-5 http://gnomad.broadinstitute.org/variant/17-78085800-T-C
Variant2: NM_000152.4:c.1688A>T (p.Gln563Leu)
CAID: CA401368995 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.1688A%3ET
gnomAD: Not in gnomAD
CaseAddInfo: Late Onset Pompe Disease
16
Case16: Male, 6 years onset, 12.5 years diagnosis, 13 years report
CasePresentingHPOs: HP:0003325, HP:0003327, HP:0003236, HP:0003691 (Limb-girdle muscle weakness, Axial muscle weakness, Increased serum CK, Scapula alata)
CaseAddInfo: Late-Onset Pompe Disease
P1
PatientF1P1: Female, 30 years onset, 40 years diagnosis, Caucasian
CasePresentingHPOs: HP:0007340, HP:0002172 (Leg weakness, Postural instability)
HPOsFreeText: History of hyperCKemia greater than 1,000 U/L (control 30–220 U/L), Showed deficient muscle acid GAA activity (0.05 µmol/min/g, control >0.42 µmol/min/g)
CaseAddInfo: First cousin twice removed of F1P3, Proband
Case 1
Case#: Case 1, Boy, Death at 6-7 months old, Hispanic
DiseaseAssertion: Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: HP:0002240, HP:0001640, 0000961, HP:0002090, HP:0001270, HP:0031664, HP:0200128, HP:0001252
(Hepatomegaly, Cardiomegaly, Cyanosis, Pneumonia, Motor delay, Systolic heart murmur, Biventricular hypertrophy, Muscular Hypotonia)
CaseHPOFreeText: Heart failure, Systolic murmur grade II-III, Enlarged, EKG showed an inverted T wave from V4-V6 as well as AVF, suggesting left systolic overload.
CaseNotHPOs:
CaseNotHPOFreeText:
CasePreviousTesting: Ejection fraction of 52%
Serum creatine kinase was 386 IU/L (mildly elevated)
GAA activity on dried blood spot was decreased (1.08 nmol/L; normal range: 1.5-10 nmol/L)
Whole exon and exon-intron boundaries direct sequencing revealed a homozygous single base deletion c.1987delC
Variant: c.1987delC
ClinVar: N/A
CAID: N/A
gnomAD: N/A
ParentalGenotype: N/A
PreviouslyPublished: N/A
31
Case31: Male, 41yo (at enrollment and onset)
CasePresentingHPOs: HP:0002094, HP:0003701, HP:0003327, HP:0003236, HP:0002098, HP:0002111, HP:0003458, HP:0100284
HPOsFreeText: asymmetric weakness of extremities, CK = 573 IU/L, required use of ventilator, FVC = 33.7%, unspecific myopathic changes present in muscle pathology, DBS GAA activity = .05, mixed leukocyte GAA activity = 1.40
CaseNotHPOs: HP:0001627
NotHPOsFreeText:
CaseAddInfo:
CasePreviousTesting: clinical history, laboratory data, DBS and ML assays to measure GAA activity, electromyography, muscle pathology analysis
CaseGenotypingMethod: full sequencing of GAA gene
VariantAllele1: NM_000152.3:c.1822C>T
CAID: CA8815488, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.3%3Ac.1822C%3ET
gnomAD: 0.00001806, http://gnomad.broadinstitute.org/variant/17-78086444-C-T
VariantAllele2: NM_000152.4(GAA):c.2238G>C (p.Trp746Cys)
ClinVar: 265160, https://www.ncbi.nlm.nih.gov/clinvar/variation/265160/
gnomAD: 0.0002987, http://exac.broadinstitute.org/variant/17-78090815-G-C
34-year-old affected daughter
Patient2: Female, 34 years report, Iranian, Iran
CasePresentingHPOs: HP:0002098, HP:0003236, HP:0002910 (Respiratory distress, Increased serum CK, Increased transaminases)
HPOsFreeText: GAA measurement from dried blood specimen at pH 3.8 was 0.13 nmol/spot * 21 h (ref 0.9-7.2) with acarbose and 0.65 nmol/spot * 21 h (ref 1.5-10) without acarbose and 3.84 nmol/spot * 21 h at pH 7.0 (ref 1.8-17.1), AST levels at 165 (ref 0-45), ALT levels at 261 (ref 5-40), CPK levels at 1212 (ref 25-200), FEV1 at 0.83, FEV1/FVC at 90.25
CaseAddInfo: Sibling of P1
5/M
Patient5: Male, Hispanic, 14yo
CasePresentingHPOs:
HPOsFreeText: IOPD, rhGAA IgG antibody titer = 200, CRIM positive
CaseNotHPOs:
NotHPOsFreeText: no infusion associated reactions
CaseAddInfo: homozygous, 6.8mo at diagnosis, 7.3mo at ERT start
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant: NM_000152.4(GAA):c.2297A>C (p.Tyr766Ser)
ClinVar: 420102, https://www.ncbi.nlm.nih.gov/clinvar/variation/420102/
gnomAD: 0.000003998, https://gnomad.broadinstitute.org/variant/17-78090874-A-C